BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, Mckay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism 2006;3:87-98. [DOI: 10.1016/j.cmet.2006.01.005] [Cited by in Crossref: 1457] [Cited by in F6Publishing: 1388] [Article Influence: 91.1] [Reference Citation Analysis]
Number Citing Articles
1 Alexander R, Lodish H, Sun L. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets 2011;15:623-36. [PMID: 21355787 DOI: 10.1517/14728222.2011.561317] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 7.6] [Reference Citation Analysis]
2 Müller G. Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes 2012;5:247-82. [PMID: 22924003 DOI: 10.2147/DMSO.S32923] [Cited by in Crossref: 97] [Cited by in F6Publishing: 46] [Article Influence: 9.7] [Reference Citation Analysis]
3 Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203-222. [PMID: 28209991 DOI: 10.1038/nrd.2016.246] [Cited by in Crossref: 1780] [Cited by in F6Publishing: 1843] [Article Influence: 356.0] [Reference Citation Analysis]
4 Włodarski A, Strycharz J, Wróblewski A, Kasznicki J, Drzewoski J, Śliwińska A. The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress. Int J Mol Sci 2020;21:E6902. [PMID: 32962281 DOI: 10.3390/ijms21186902] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
5 Goedeke L, Fernández-Hernando C. MicroRNAs: a connection between cholesterol metabolism and neurodegeneration. Neurobiol Dis 2014;72 Pt A:48-53. [PMID: 24907491 DOI: 10.1016/j.nbd.2014.05.034] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
6 Herkenhoff ME, Oliveira AC, Nachtigall PG, Costa JM, Campos VF, Hilsdorf AWS, Pinhal D. Fishing Into the MicroRNA Transcriptome. Front Genet 2018;9:88. [PMID: 29616080 DOI: 10.3389/fgene.2018.00088] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
7 Fu X, Dong B, Tian Y, Lefebvre P, Meng Z, Wang X, Pattou F, Han W, Wang X, Lou F, Jove R, Staels B, Moore DD, Huang W. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids. J Clin Invest 2015;125:2497-509. [PMID: 25961460 DOI: 10.1172/JCI75438] [Cited by in Crossref: 128] [Cited by in F6Publishing: 66] [Article Influence: 18.3] [Reference Citation Analysis]
8 Connelly CM, Thomas M, Deiters A. High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function. J Biomol Screen. 2012;17:822-828. [PMID: 22412086 DOI: 10.1177/1087057112439606] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
9 Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 2010;62:1733-43. [PMID: 20201077 DOI: 10.1002/art.27443] [Cited by in Crossref: 373] [Cited by in F6Publishing: 347] [Article Influence: 31.1] [Reference Citation Analysis]
10 Párrizas M, Novials A. Circulating microRNAs as biomarkers for metabolic disease. Best Practice & Research Clinical Endocrinology & Metabolism 2016;30:591-601. [DOI: 10.1016/j.beem.2016.08.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
11 Hildebrandt-Eriksen ES, Aarup V, Persson R, Hansen HF, Munk ME, Ørum H. A locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeys. Nucleic Acid Ther. 2012;22:152-161. [PMID: 22545703 DOI: 10.1089/nat.2011.0332] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 6.8] [Reference Citation Analysis]
12 Krützfeldt J, Poy MN, Stoffel M. Strategies to determine the biological function of microRNAs. Nat Genet. 2006;38 Suppl:S14-S19. [PMID: 16736018 DOI: 10.1038/ng1799] [Cited by in Crossref: 169] [Cited by in F6Publishing: 168] [Article Influence: 10.6] [Reference Citation Analysis]
13 Li JY, Yong TY, Michael MZ, Gleadle JM. MicroRNAs: are they the missing link between hypoxia and pre-eclampsia? Hypertens Pregnancy 2014;33:102-14. [PMID: 24354525 DOI: 10.3109/10641955.2013.832772] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
14 Liu J, Ye C, Liu W, Zhao W, Zhang YJ, Zhang H, Ying H. AICAR enhances insulin signaling via downregulation of miR-29. Can J Physiol Pharmacol 2016;94:199-205. [PMID: 26359920 DOI: 10.1139/cjpp-2015-0159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
15 Conrad KD, Niepmann M. The role of microRNAs in hepatitis C virus RNA replication. Arch Virol 2014;159:849-62. [PMID: 24158346 DOI: 10.1007/s00705-013-1883-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
16 Maroney PA, Yu Y, Fisher J, Nilsen TW. Evidence that microRNAs are associated with translating messenger RNAs in human cells. Nat Struct Mol Biol. 2006;13:1102-1107. [PMID: 17128271 DOI: 10.1038/nsmb1174] [Cited by in Crossref: 207] [Cited by in F6Publishing: 202] [Article Influence: 12.9] [Reference Citation Analysis]
17 Singh D, Kashyap A, Pandey RV, Saini KS. Novel advances in cytochrome P450 research. Drug Discovery Today 2011;16:793-9. [DOI: 10.1016/j.drudis.2011.08.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
18 Li H, Chen X, Guan L, Qi Q, Shu G, Jiang Q, Yuan L, Xi Q, Zhang Y. MiRNA-181a regulates adipogenesis by targeting tumor necrosis factor-α (TNF-α) in the porcine model. PLoS One 2013;8:e71568. [PMID: 24098322 DOI: 10.1371/journal.pone.0071568] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
19 Chan KK, Liu Z, Xie Z, Chiu M, Wang H, Chen P, Dunkerson S, Chiu M, Liu S, Triantafillou G, Garzon R, Croce CM, Byrd JC, Muthusamy N, Marcucci G. A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo application. AAPS J 2010;12:556-68. [PMID: 20625866 DOI: 10.1208/s12248-010-9214-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
20 Fiorino S, Bacchi-Reggiani L, Sabbatani S, Grizzi F, di Tommaso L, Masetti M, Fornelli A, Bondi A, de Biase D, Visani M. Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review. Br J Nutr. 2014;112:1751-1768. [PMID: 25325563 DOI: 10.1017/s0007114514002839] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
21 Lee J, Kim Y, Friso S, Choi SW. Epigenetics in non-alcoholic fatty liver disease. Mol Aspects Med. 2016; Nov 23. [Epub ahead of print]. [PMID: 27889327 DOI: 10.1016/j.mam.2016.11.008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 9.7] [Reference Citation Analysis]
22 Hu J, Xu Y, Hao J, Wang S, Li C, Meng S. MiR-122 in hepatic function and liver diseases. Protein Cell 2012;3:364-71. [PMID: 22610888 DOI: 10.1007/s13238-012-2036-3] [Cited by in Crossref: 110] [Cited by in F6Publishing: 111] [Article Influence: 11.0] [Reference Citation Analysis]
23 Sayed D, Abdellatif M. MicroRNAs in Development and Disease. Physiological Reviews 2011;91:827-87. [DOI: 10.1152/physrev.00006.2010] [Cited by in Crossref: 691] [Cited by in F6Publishing: 675] [Article Influence: 62.8] [Reference Citation Analysis]
24 Paul B, Tollefsbol TO. Outline of Epigenetics. Epigenetics in Psychiatry. Elsevier; 2014. pp. 27-44. [DOI: 10.1016/b978-0-12-417114-5.00002-4] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
25 Kalaki-jouybari F, Shanaki M, Delfan M, Gorgani-firouzjae S, Khakdan S. High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats. Archives of Physiology and Biochemistry 2020;126:242-9. [DOI: 10.1080/13813455.2018.1510968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Lynn FC. Meta-regulation: microRNA regulation of glucose and lipid metabolism. Trends in Endocrinology & Metabolism 2009;20:452-9. [DOI: 10.1016/j.tem.2009.05.007] [Cited by in Crossref: 132] [Cited by in F6Publishing: 122] [Article Influence: 10.2] [Reference Citation Analysis]
27 Jin BX, Zhang YH, Jin WJ, Sun XY, Qiao GF, Wei YY, Sun LB, Zhang WH, Li N. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis. Sci Rep. 2015;5:15026. [PMID: 26456479 DOI: 10.1038/srep15026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
28 Pea A, Jamieson NB, Braconi C. Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma. Hepatology 2021;73 Suppl 1:38-48. [PMID: 32160335 DOI: 10.1002/hep.31225] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
29 Zhao H, Shen J, Daniel-MacDougall C, Wu X, Chow WH. Plasma MicroRNA signature predicting weight gain among Mexican-American women. Obesity (Silver Spring) 2017;25:958-64. [PMID: 28342299 DOI: 10.1002/oby.21824] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
30 Zhu T, Corraze G, Plagnes-Juan E, Skiba-Cassy S. Circulating miRNA measurements are reflective of cholesterol-based changes in rainbow trout (Oncorhynchus mykiss). PLoS One 2018;13:e0206727. [PMID: 30395627 DOI: 10.1371/journal.pone.0206727] [Reference Citation Analysis]
31 Zhang B, Wang Q, Pan X. MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 2007;210:279-89. [DOI: 10.1002/jcp.20869] [Cited by in Crossref: 380] [Cited by in F6Publishing: 349] [Article Influence: 23.8] [Reference Citation Analysis]
32 Madrigal-Matute J, Rotllan N, Aranda JF, Fernández-Hernando C. MicroRNAs and atherosclerosis. Curr Atheroscler Rep 2013;15:322. [PMID: 23512606 DOI: 10.1007/s11883-013-0322-z] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 10.0] [Reference Citation Analysis]
33 Karere GM, Glenn JP, VandeBerg JL, Cox LA. Identification of baboon microRNAs expressed in liver and lymphocytes. J Biomed Sci 2010;17:54. [PMID: 20594335 DOI: 10.1186/1423-0127-17-54] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
34 Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha R, Banfi C, Stubbs A, Calin GA, Ivan M. An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem. 2009;284:35134-35143. [PMID: 19826008 DOI: 10.1074/jbc.m109.052779] [Cited by in Crossref: 192] [Cited by in F6Publishing: 122] [Article Influence: 14.8] [Reference Citation Analysis]
35 Hennessy EJ, Moore KJ. Using microRNA as an alternative treatment for hyperlipidemia and cardiovascular disease: cardio-miRs in the pipeline. J Cardiovasc Pharmacol 2013;62:247-54. [PMID: 23743768 DOI: 10.1097/FJC.0b013e31829d48bf] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
36 Jin H, Tuo W, Lian H, Liu Q, Zhu XQ, Gao H. Strategies to identify microRNA targets: new advances. N Biotechnol 2010;27:734-8. [PMID: 20888440 DOI: 10.1016/j.nbt.2010.09.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
37 Tzur G, Levy A, Meiri E, Barad O, Spector Y, Bentwich Z, Mizrahi L, Katzenellenbogen M, Ben-Shushan E, Reubinoff BE. MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cells. PLoS One. 2008;3:e3726. [PMID: 19015728 DOI: 10.1371/journal.pone.0003726] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 5.4] [Reference Citation Analysis]
38 Shilo S, Roy S, Khanna S, Sen CK. MicroRNA in Cutaneous Wound Healing: A New Paradigm. DNA and Cell Biology 2007;26:227-37. [DOI: 10.1089/dna.2006.0568] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
39 Miyaaki H, Ichikawa T, Kamo Y, Taura N, Honda T, Shibata H, Milazzo M, Fornari F, Gramantieri L, Bolondi L. Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease. Liver Int. 2014;34:e302-e307. [PMID: 24313922 DOI: 10.1111/liv.12429] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 10.5] [Reference Citation Analysis]
40 Huynh C, Segura MF, Gaziel-Sovran A, Menendez S, Darvishian F, Chiriboga L, Levin B, Meruelo D, Osman I, Zavadil J. Efficient in vivo microRNA targeting of liver metastasis. Oncogene. 2011;30:1481-1488. [PMID: 21102518 DOI: 10.1038/onc.2010.523] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
41 Nahar S, Singh A, Morihiro K, Moai Y, Kodama T, Obika S, Maiti S. Systematic Evaluation of Biophysical and Functional Characteristics of Selenomethylene-Locked Nucleic Acid-Mediated Inhibition of miR-21. Biochemistry 2016;55:7023-32. [PMID: 27992999 DOI: 10.1021/acs.biochem.6b00895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
42 Chen YT, Yang QY, Hu Y, Liu XD, de Avila JM, Zhu MJ, Nathanielsz PW, Du M. Imprinted lncRNA Dio3os preprograms intergenerational brown fat development and obesity resistance. Nat Commun 2021;12:6845. [PMID: 34824246 DOI: 10.1038/s41467-021-27171-1] [Reference Citation Analysis]
43 Gläser C, Wichmann T, Wagner U, Gabert A, Schneider R. [Scanning electron microscopy studies in the detection of apo-B,E receptor activity of the lymphocyte membrane for diagnostic verification of genetically determined disorders of lipid metabolism]. Wien Klin Wochenschr. 1988;100:613-618. [PMID: 2847432 DOI: 10.1161/circulationaha.109.889048] [Cited by in Crossref: 420] [Cited by in F6Publishing: 268] [Article Influence: 12.4] [Reference Citation Analysis]
44 Sayed D, Rane S, Abdellatif M. MicroRNAs challenge the status quo of therapeutic targeting. J Cardiovasc Transl Res. 2009;2:100-107. [PMID: 20559973 DOI: 10.1007/s12265-008-9052-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
45 Sun BK, Tsao H. Small RNAs in development and disease. J Am Acad Dermatol 2008;59:725-37; quiz 738-40. [PMID: 19119093 DOI: 10.1016/j.jaad.2008.08.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
46 Su D, Zhang R, Hou F, Chi J, Huang F, Yan S, Liu L, Deng Y, Wei Z, Zhang M. Lychee pulp phenolics ameliorate hepatic lipid accumulation by reducing miR-33 and miR-122 expression in mice fed a high-fat diet. Food Funct 2017;8:808-15. [DOI: 10.1039/c6fo01507g] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 6.4] [Reference Citation Analysis]
47 de Lucia C, Komici K, Borghetti G, Femminella GD, Bencivenga L, Cannavo A, Corbi G, Ferrara N, Houser SR, Koch WJ, Rengo G. microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases. Front Med (Lausanne) 2017;4:74. [PMID: 28660188 DOI: 10.3389/fmed.2017.00074] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 8.8] [Reference Citation Analysis]
48 Eken SM, Jin H, Chernogubova E, Maegdefessel L. Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction. J Diabetes Res 2013;2013:834727. [PMID: 24369540 DOI: 10.1155/2013/834727] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
49 Ohno M, Shibata C, Kishikawa T, Yoshikawa T, Takata A, Kojima K, Akanuma M, Kang YJ, Yoshida H, Otsuka M, Koike K. The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice. Sci Rep 2013;3:2553. [PMID: 23989853 DOI: 10.1038/srep02553] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
50 Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287-314. [PMID: 24079833 DOI: 10.1146/annurev-pathol-012513-104715] [Cited by in Crossref: 929] [Cited by in F6Publishing: 952] [Article Influence: 103.2] [Reference Citation Analysis]
51 Chen H, Yang J, Tan Z. Upregulation of microRNA-9-5p inhibits apoptosis of chondrocytes through downregulating Tnc in mice with osteoarthritis following tibial plateau fracture. J Cell Physiol 2019;234:23326-36. [PMID: 31169312 DOI: 10.1002/jcp.28900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
52 Huang M, Chen L, Shen Y, Chen J, Guo X, Xu N. Integrated mRNA and miRNA profile expression in livers of Jinhua and Landrace pigs. Asian-Australas J Anim Sci 2019;32:1483-90. [PMID: 31010989 DOI: 10.5713/ajas.18.0807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
53 Mata M, Neben S, Majzoub K, Carette J, Ramanathan M, Khavari PA, Sarnow P. Impact of a patient-derived hepatitis C viral RNA genome with a mutated microRNA binding site. PLoS Pathog 2019;15:e1007467. [PMID: 31075158 DOI: 10.1371/journal.ppat.1007467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
54 Huang HY, Liu RR, Zhao GP, Li QH, Zheng MQ, Zhang JJ, Li SF, Liang Z, Wen J. Integrated analysis of microRNA and mRNA expression profiles in abdominal adipose tissues in chickens. Sci Rep 2015;5:16132. [PMID: 26531148 DOI: 10.1038/srep16132] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
55 Liu J, Ning C, Li B, Li R, Wu W, Liu H. Hepatic microRNAome reveals potential microRNA-mRNA pairs association with lipid metabolism in pigs. Asian-Australas J Anim Sci 2019;32:1458-68. [PMID: 30208692 DOI: 10.5713/ajas.18.0438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 von Hahn T, Steinmann E, Ciesek S, Pietschmann T. Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches. Expert Rev Gastroenterol Hepatol. 2010;4:63-79. [PMID: 20136590 DOI: 10.1586/egh.09.74] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
57 Shilo V, Mor-Yosef Levi I, Abel R, Mihailović A, Wasserman G, Naveh-Many T, Ben-Dov IZ. Let-7 and MicroRNA-148 Regulate Parathyroid Hormone Levels in Secondary Hyperparathyroidism. J Am Soc Nephrol 2017;28:2353-63. [PMID: 28298326 DOI: 10.1681/ASN.2016050585] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
58 Zhang ZC, Liu Y, Xiao LL, Li SF, Jiang JH, Zhao Y, Qian SW, Tang QQ, Li X. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice. J Hepatol. 2015;63:1466-1475. [PMID: 26272872 DOI: 10.1016/j.jhep.2015.07.037] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
59 Kato M. Target RNA-directed microRNA degradation; which controls which? Noncoding RNA Investig 2018;2:62. [PMID: 30957073 DOI: 10.21037/ncri.2018.11.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
60 Patil KM, Chen G. Recognition of RNA Sequence and Structure by Duplex and Triplex Formation: Targeting miRNA and Pre-miRNA. In: Jurga S, Erdmann VA, Barciszewski J, editors. Modified Nucleic Acids in Biology and Medicine. Cham: Springer International Publishing; 2016. pp. 299-317. [DOI: 10.1007/978-3-319-34175-0_13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
61 Jadhav V, Hackl M, Druz A, Shridhar S, Chung CY, Heffner KM, Kreil DP, Betenbaugh M, Shiloach J, Barron N, Grillari J, Borth N. CHO microRNA engineering is growing up: recent successes and future challenges. Biotechnol Adv 2013;31:1501-13. [PMID: 23916872 DOI: 10.1016/j.biotechadv.2013.07.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 6.7] [Reference Citation Analysis]
62 Tan Y, Pan T, Ye Y, Ge G, Chen L, Wen D, Zou S. Serum microRNAs as potential biomarkers of primary biliary cirrhosis. PLoS One. 2014;9:e111424. [PMID: 25347847 DOI: 10.1371/journal.pone.0111424] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
63 He Y, Huang M, Tang C, Yue Y, Liu X, Zheng Z, Dong H, Liu D. Dietary daidzein inhibits hepatitis C virus replication by decreasing microRNA-122 levels. Virus Res 2021;298:198404. [PMID: 33775754 DOI: 10.1016/j.virusres.2021.198404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Montag J, Brameier M, Schmädicke AC, Gilch S, Schätzl HM, Motzkus D. A genome-wide survey for prion-regulated miRNAs associated with cholesterol homeostasis. BMC Genomics 2012;13:486. [PMID: 22985096 DOI: 10.1186/1471-2164-13-486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
65 Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest. 2011;121:2921-2931. [PMID: 21646721 DOI: 10.1172/jci57275] [Cited by in Crossref: 473] [Cited by in F6Publishing: 283] [Article Influence: 43.0] [Reference Citation Analysis]
66 Rabieian R, Boshtam M, Zareei M, Kouhpayeh S, Masoudifar A, Mirzaei H. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis. J Cell Biochem 2018;119:17-27. [PMID: 28520219 DOI: 10.1002/jcb.26146] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 15.8] [Reference Citation Analysis]
67 De Laet N, Madder A. Synthesis and evaluation of methylene blue oligonucleotide conjugates for DNA interstrand cross-linking. Journal of Photochemistry and Photobiology A: Chemistry 2016;318:64-70. [DOI: 10.1016/j.jphotochem.2015.11.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
68 Kang L, Fan Z, Sun H, Feng Y, Ma C, Yan P, Zhang C, Ma H, Hao P, Chen X, Zheng Z, Xu X, Wang R. Improved synthesis and biological evaluation of Tc-99m radiolabeled AMO for miRNA imaging in tumor xenografts. J Labelled Comp Radiopharm 2015;58:461-8. [PMID: 26503645 DOI: 10.1002/jlcr.3351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
69 Li H, Yu XH, Ou X, Ouyang XP, Tang CK. Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. Prog Lipid Res 2021;83:101109. [PMID: 34097928 DOI: 10.1016/j.plipres.2021.101109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
70 Ulitsky I, Laurent LC, Shamir R. Towards computational prediction of microRNA function and activity. Nucleic Acids Res 2010;38:e160. [PMID: 20576699 DOI: 10.1093/nar/gkq570] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
71 López-Sánchez GN, Dóminguez-Pérez M, Uribe M, Chávez-Tapia NC, Nuño-Lámbarri N. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease. Ann Hepatol 2021;21:100212. [PMID: 32533953 DOI: 10.1016/j.aohep.2020.04.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Xu H, He JH, Xiao ZD, Zhang QQ, Chen YQ, Zhou H, Qu LH. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology. 2010;52:1431-1442. [PMID: 20842632 DOI: 10.1002/hep.23818] [Cited by in Crossref: 183] [Cited by in F6Publishing: 193] [Article Influence: 15.3] [Reference Citation Analysis]
73 Banerjee J, Chan YC, Sen CK. MicroRNAs in skin and wound healing. Physiol Genomics 2011;43:543-56. [PMID: 20959495 DOI: 10.1152/physiolgenomics.00157.2010] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 6.9] [Reference Citation Analysis]
74 Caporarello N, Lupo G, Olivieri M, Cristaldi M, Cambria MT, Salmeri M, Anfuso CD. Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions (Review). Mol Med Rep 2017;16:4393-402. [PMID: 28791360 DOI: 10.3892/mmr.2017.7179] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
75 Juanola O, Martínez-López S, Francés R, Gómez-Hurtado I. Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. Int J Environ Res Public Health 2021;18:5227. [PMID: 34069012 DOI: 10.3390/ijerph18105227] [Reference Citation Analysis]
76 Qiao JY, Li HW, Liu FG, Li YC, Tian S, Cao LH, Hu K, Wu XX, Miao MS. Effects of Portulaca Oleracea Extract on Acute Alcoholic Liver Injury of Rats. Molecules 2019;24:E2887. [PMID: 31398934 DOI: 10.3390/molecules24162887] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
77 Maher JJ. New insights from rodent models of fatty liver disease. Antioxid Redox Signal 2011;15:535-50. [PMID: 21126212 DOI: 10.1089/ars.2010.3749] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
78 Smolle E, Haybaeck J. Non-coding RNAs and lipid metabolism. Int J Mol Sci 2014;15:13494-513. [PMID: 25093715 DOI: 10.3390/ijms150813494] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
79 Rotllan N, Fernández-Hernando C. MicroRNA Regulation of Cholesterol Metabolism. Cholesterol 2012;2012:847849. [PMID: 22919472 DOI: 10.1155/2012/847849] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
80 Boesch-Saadatmandi C, Wagner AE, Wolffram S, Rimbach G. Effect of quercetin on inflammatory gene expression in mice liver in vivo - role of redox factor 1, miRNA-122 and miRNA-125b. Pharmacol Res. 2012;65:523-530. [PMID: 22402395 DOI: 10.1016/j.phrs.2012.02.007] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 8.3] [Reference Citation Analysis]
81 Canfrán-Duque A, Ramírez CM, Goedeke L, Lin CS, Fernández-Hernando C. microRNAs and HDL life cycle. Cardiovasc Res 2014;103:414-22. [PMID: 24895349 DOI: 10.1093/cvr/cvu140] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
82 Caligiuri A, Gentilini A, Marra F. Molecular Pathogenesis of NASH. Int J Mol Sci. 2016;17. [PMID: 27657051 DOI: 10.3390/ijms17091575] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 13.2] [Reference Citation Analysis]
83 Parra P, Serra F, Palou A. Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS One 2010;5:e13005. [PMID: 20886002 DOI: 10.1371/journal.pone.0013005] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 6.7] [Reference Citation Analysis]
84 Baradan R, Hollander JM, Das S. Mitochondrial miRNAs in diabetes: just the tip of the iceberg. Can J Physiol Pharmacol 2017;95:1156-62. [PMID: 28467860 DOI: 10.1139/cjpp-2016-0580] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
85 Lundin KE, Højland T, Hansen BR, Persson R, Bramsen JB, Kjems J, Koch T, Wengel J, Smith CI. Biological activity and biotechnological aspects of locked nucleic acids. Adv Genet 2013;82:47-107. [PMID: 23721720 DOI: 10.1016/B978-0-12-407676-1.00002-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
86 Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007;91:209-17. [PMID: 17521938 DOI: 10.1016/j.ymgme.2007.03.011] [Cited by in Crossref: 232] [Cited by in F6Publishing: 221] [Article Influence: 15.5] [Reference Citation Analysis]
87 Cheung O, Sanyal AJ. Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol. 2009;25:230-237. [PMID: 19396962 DOI: 10.1097/MOG.0b013e3283294a18] [Cited by in Crossref: 54] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
88 Yeh C, Chen T, Wang Y, Lin Y, Fang S. MicroRNA-27a Regulates Cardiomyocytic Apoptosis During Cardioplegia-Induced Cardiac Arrest by Targeting Interleukin 10–Related Pathways. Shock 2012;38:607-14. [DOI: 10.1097/shk.0b013e318271f944] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
89 Zhang J, Wang Q, Zhao X, Wang L, Wang X, Wang J, Dong B, Gong D. MicroRNA-122 targets genes related to goose fatty liver. Poult Sci 2018;97:643-9. [PMID: 29182758 DOI: 10.3382/ps/pex307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
90 Connelly CM, Deiters A. Cellular microRNA sensors based on luciferase reporters. Methods Mol Biol 2014;1095:135-46. [PMID: 24166309 DOI: 10.1007/978-1-62703-703-7_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
91 Liu XL, Cao HX, Wang BC, Xin FZ, Zhang RN, Zhou D, Yang RX, Zhao ZH, Pan Q, Fan JG. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1. World J Gastroenterol 2017; 23(46): 8140-8151 [PMID: 29290651 DOI: 10.3748/wjg.v23.i46.8140] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
92 Nishida K, Shimozuru M, Okamatsu-Ogura Y, Miyazaki M, Soma T, Sashika M, Tsubota T. Changes in liver microRNA expression and their possible regulatory role in energy metabolism-related genes in hibernating black bears. J Comp Physiol B 2021;191:397-409. [PMID: 33459845 DOI: 10.1007/s00360-020-01337-7] [Reference Citation Analysis]
93 Rimbach G, Moehring J, Huebbe P, Lodge JK. Gene-regulatory activity of alpha-tocopherol. Molecules. 2010;15:1746-1761. [PMID: 20336011 DOI: 10.3390/molecules15031746] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
94 Alkandari A, Ashrafian H, Sathyapalan T, Sedman P, Darzi A, Holmes E, Athanasiou T, Atkin SL, Gooderham NJ. Improved physiology and metabolic flux after Roux-en-Y gastric bypass is associated with temporal changes in the circulating microRNAome: a longitudinal study in humans. BMC Obes 2018;5:20. [PMID: 29881628 DOI: 10.1186/s40608-018-0199-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
95 Shvangiradze TA, Bondarenko IZ, Troshina EA, Shestakova MV. [MiRNAs in the diagnosis of cardiovascular diseases associated with type 2 diabetes mellitus and obesity]. Ter Arkh 2016;88:87-92. [PMID: 28635856 DOI: 10.17116/terarkh201688687-92] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
96 van der Ree MH, van der Meer AJ, van Nuenen AC, de Bruijne J, Ottosen S, Janssen HL, Kootstra NA, Reesink HW. Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma. Aliment Pharmacol Ther 2016;43:102-13. [PMID: 26503793 DOI: 10.1111/apt.13432] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 12.1] [Reference Citation Analysis]
97 Long JM, Lahiri DK. Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders. Exp Neurol 2012;235:402-18. [PMID: 22245616 DOI: 10.1016/j.expneurol.2011.12.043] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
98 López-Pastor AR, Infante-Menéndez J, Escribano Ó, Gómez-Hernández A. miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease. Front Med (Lausanne) 2020;7:527059. [PMID: 33102495 DOI: 10.3389/fmed.2020.527059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
99 Zhao F. Dysregulated Epigenetic Modifications in the Pathogenesis of NAFLD-HCC. In: Yu J, editor. Obesity, Fatty Liver and Liver Cancer. Singapore: Springer; 2018. pp. 79-93. [DOI: 10.1007/978-981-10-8684-7_7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
100 Sendi H, Mehrab-Mohseni M, Foureau DM, Ghosh S, Walling TL, Steuerwald N, Zamor PJ, Kaplan KJ, Jacobs C, Ahrens WA, Russo MW, Clemens MG, Schrum LW, Bonkovsky HL. MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA. Liver Int 2015;35:1315-23. [PMID: 25302477 DOI: 10.1111/liv.12698] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
101 Donaldson CJ, Lao KH, Zeng L. The salient role of microRNAs in atherogenesis. Journal of Molecular and Cellular Cardiology 2018;122:98-113. [DOI: 10.1016/j.yjmcc.2018.08.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
102 Norata GD, Sala F, Catapano AL, Fernández-Hernando C. MicroRNAs and lipoproteins: a connection beyond atherosclerosis? Atherosclerosis 2013;227:209-15. [PMID: 23260873 DOI: 10.1016/j.atherosclerosis.2012.11.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
103 Abdelfattah AM, Park C, Choi MY. Update on non-canonical microRNAs. Biomol Concepts. 2014;5:275-287. [PMID: 25372759 DOI: 10.1515/bmc-2014-0012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 8.7] [Reference Citation Analysis]
104 Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, Smith R, Leeson B, Beard R, Lamb JR, Lim L, Mao M, Dai H, Luk JM. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol. 2010;6:402. [PMID: 20739924 DOI: 10.1038/msb.2010.58] [Cited by in Crossref: 126] [Cited by in F6Publishing: 127] [Article Influence: 11.5] [Reference Citation Analysis]
105 Zeisel MB, Pfeffer S, Baumert TF. miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo. J Hepatol. 2013;58:821-823. [PMID: 23085250 DOI: 10.1016/j.jhep.2012.10.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
106 Liu L, Qian K, Wang C. Discovery of porcine miRNA-196a/b may influence porcine adipogenesis in longissimus dorsi muscle by miRNA sequencing. Anim Genet 2017;48:175-81. [DOI: 10.1111/age.12520] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
107 Yu A. Role of microRNAs in the regulation of drug metabolism and disposition. Expert Opinion on Drug Metabolism & Toxicology 2009;5:1513-28. [DOI: 10.1517/17425250903307448] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
108 Nakanishi N, Nakagawa Y, Tokushige N, Aoki N, Matsuzaka T, Ishii K, Yahagi N, Kobayashi K, Yatoh S, Takahashi A, Suzuki H, Urayama O, Yamada N, Shimano H. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun 2009;385:492-6. [PMID: 19460359 DOI: 10.1016/j.bbrc.2009.05.058] [Cited by in Crossref: 127] [Cited by in F6Publishing: 120] [Article Influence: 9.8] [Reference Citation Analysis]
109 Howell LS, Ireland L, Park BK, Goldring CE. MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury. Expert Rev Mol Diagn 2018;18:47-54. [PMID: 29235390 DOI: 10.1080/14737159.2018.1415145] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
110 Tang Y, Liu M, Zhao Z, Li Q, Liang X, Tian J, Zhao S. Fluorometric determination of microRNA-122 by using ExoIII-aided recycling amplification and polythymine induced formation of copper nanoparticles. Mikrochim Acta 2019;186:133. [PMID: 30707302 DOI: 10.1007/s00604-019-3237-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
111 Pandey M, Ojha D, Bansal S, Rode AB, Chawla G. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases. Mol Aspects Med 2021;:101003. [PMID: 34332771 DOI: 10.1016/j.mam.2021.101003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Yamaura Y, Nakajima M, Tatsumi N, Takagi S, Fukami T, Tsuneyama K, Yokoi T. Changes in the expression of miRNAs at the pericentral and periportal regions of the rat liver in response to hepatocellular injury: comparison with the changes in the expression of plasma miRNAs. Toxicology 2014;322:89-98. [PMID: 24863736 DOI: 10.1016/j.tox.2014.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
113 Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M. An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell. 2011;147:1233-1247. [PMID: 22153071 DOI: 10.1016/j.cell.2011.10.043] [Cited by in Crossref: 331] [Cited by in F6Publishing: 331] [Article Influence: 33.1] [Reference Citation Analysis]
114 Xu J, Hu G, Lu M, Xiong Y, Li Q, Chang CC, Song B, Chang T, Li B. MiR-9 reduces human acyl-coenzyme A:cholesterol acyltransferase-1 to decrease THP-1 macrophage-derived foam cell formation. Acta Biochim Biophys Sin (Shanghai). 2013;45:953-962. [PMID: 24028971 DOI: 10.1093/abbs/gmt096] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
115 Mehta N, Cheng HY. Micro-managing the circadian clock: The role of microRNAs in biological timekeeping. J Mol Biol 2013;425:3609-24. [PMID: 23142644 DOI: 10.1016/j.jmb.2012.10.022] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
116 Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009;285:116-26. [PMID: 19464788 DOI: 10.1016/j.canlet.2009.04.031] [Cited by in Crossref: 289] [Cited by in F6Publishing: 280] [Article Influence: 22.2] [Reference Citation Analysis]
117 Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M. microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis. Front Physiol. 2012;3:49. [PMID: 22457651 DOI: 10.3389/fphys.2012.00049] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 9.4] [Reference Citation Analysis]
118 Ding Y, Li G, Zhou Z, Deng T. Molecular mechanisms underlying hepatitis C virus infection-related diabetes. Metabolism 2021;121:154802. [PMID: 34090869 DOI: 10.1016/j.metabol.2021.154802] [Reference Citation Analysis]
119 Monaghan M, Pandit A. RNA interference therapy via functionalized scaffolds. Adv Drug Deliv Rev 2011;63:197-208. [PMID: 21241760 DOI: 10.1016/j.addr.2011.01.006] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
120 Chang J, Guo JT, Jiang D, Guo H, Taylor JM, Block TM. Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol. 2008;82:8215-8223. [PMID: 18550664 DOI: 10.1128/jvi.02575-07] [Cited by in Crossref: 158] [Cited by in F6Publishing: 86] [Article Influence: 11.3] [Reference Citation Analysis]
121 Chuang TY, Wu HL, Chen CC, Gamboa GM, Layman LC, Diamond MP, Azziz R, Chen YH. MicroRNA-223 Expression is Upregulated in Insulin Resistant Human Adipose Tissue. J Diabetes Res 2015;2015:943659. [PMID: 26273679 DOI: 10.1155/2015/943659] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
122 Schulte C, Karakas M, Zeller T. microRNAs in cardiovascular disease - clinical application. Clin Chem Lab Med 2017;55:687-704. [PMID: 27914211 DOI: 10.1515/cclm-2016-0576] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 11.4] [Reference Citation Analysis]
123 Li S, Sun YN, Zhou YT, Zhang CL, Lu F, Liu J, Shang XM. Screening and identification of microRNA involved in unstable angina using gene-chip analysis. Exp Ther Med 2016;12:2716-22. [PMID: 27703515 DOI: 10.3892/etm.2016.3646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
124 Ye D, Zhang T, Lou G, Xu W, Dong F, Chen G, Liu Y. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients. Life Sci 2018;208:201-7. [PMID: 30030064 DOI: 10.1016/j.lfs.2018.07.029] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
125 Huleihel L, Scarritt ME, Badylak SF. The Influence of Extracellular RNA on Cell Behavior in Health, Disease and Regeneration. Curr Pathobiol Rep 2017;5:13-22. [PMID: 28944104 DOI: 10.1007/s40139-017-0121-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
126 Xu M, Zheng XM, Jiang F, Qiu WQ. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease. J Cell Biochem 2018;119:5864-74. [PMID: 29575055 DOI: 10.1002/jcb.26776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
127 Abd El-Haleim EA, Sallam NA. Vitamin D modulates hepatic microRNAs and mitigates tamoxifen-induced steatohepatitis in female rats. Fundam Clin Pharmacol 2021. [PMID: 34312906 DOI: 10.1111/fcp.12720] [Reference Citation Analysis]
128 Fernández-Hernando C. Emerging role of microRNAs in the regulation of lipid metabolism. Hepatology 2013;57:432-4. [PMID: 22806606 DOI: 10.1002/hep.25960] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
129 Menon B, Gulappa T, Menon KM. miR-122 Regulates LH Receptor Expression by Activating Sterol Response Element Binding Protein in Rat Ovaries. Endocrinology 2015;156:3370-80. [PMID: 26125464 DOI: 10.1210/en.2015-1121] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
130 Su X, Chen X, Wang B. Pathology of metabolically-related dyslipidemia. Clin Chim Acta 2021;521:107-15. [PMID: 34192528 DOI: 10.1016/j.cca.2021.06.029] [Reference Citation Analysis]
131 Babaei K, Shams S, Keymoradzadeh A, Vahidi S, Hamami P, Khaksar R, Norollahi SE, Samadani AA. An insight of microRNAs performance in carcinogenesis and tumorigenesis; an overview of cancer therapy. Life Sci. 2020;240:117077. [PMID: 31751586 DOI: 10.1016/j.lfs.2019.117077] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
132 Lu XF, Zhou YJ, Zhang L, Ji HJ, Li L, Shi YJ, Bu H. Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation. World J Gastroenterol 2015; 21(21): 6591-6603 [PMID: 26074697 DOI: 10.3748/wjg.v21.i21.6591] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
133 Wang Y, Jin P, Liu J, Xie X. Exosomal microRNA-122 mediates obesity-related cardiomyopathy through suppressing mitochondrial ADP-ribosylation factor-like 2. Clin Sci (Lond) 2019;133:1871-81. [PMID: 31434696 DOI: 10.1042/CS20190558] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
134 Sacco J, Adeli K. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol. 2012;23:220-225. [PMID: 22488426 DOI: 10.1097/mol.0b013e3283534c9f] [Cited by in Crossref: 77] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
135 Wang G, Cheng Y, Liu Y. Comprehensive Evaluation of a Donated After Circulatory Death (DCD) Donor Liver Model in Minipigs. Ann Transplant 2018;23:758-66. [DOI: 10.12659/aot.911072] [Reference Citation Analysis]
136 Manoel Alves J, Handerson Gomes Teles R, do Valle Gomes Gatto C, Muñoz VR, Regina Cominetti M, Garcia de Oliveira Duarte AC. Mapping Research in the Obesity, Adipose Tissue, and MicroRNA Field: A Bibliometric Analysis. Cells 2019;8:E1581. [PMID: 31817583 DOI: 10.3390/cells8121581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
137 Kubo E, Hasanova N, Sasaki H, Singh DP. Dynamic and differential regulation in the microRNA expression in the developing and mature cataractous rat lens. J Cell Mol Med 2013;17:1146-59. [PMID: 23844765 DOI: 10.1111/jcmm.12094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
138 Cheng X, Xi QY, Wei S, Wu D, Ye RS, Chen T, Qi QE, Jiang QY, Wang SB, Wang LN. Critical role of miR-125b in lipogenesis by targeting stearoyl-CoA desaturase-1 (SCD-1). J Anim Sci. 2016;94:65-76. [PMID: 26812313 DOI: 10.2527/jas.2015-9456] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
139 Liu L, Wan Y, Shen A, Zhao J, Lin J, Zhong X, Zhang Y, Hong Z. miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia. Evid Based Complement Alternat Med 2015;2015:365484. [PMID: 26294924 DOI: 10.1155/2015/365484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
140 Feinberg MW, Moore KJ. MicroRNA Regulation of Atherosclerosis. Circ Res. 2016;118:703-720. [PMID: 26892968 DOI: 10.1161/circresaha.115.306300] [Cited by in Crossref: 296] [Cited by in F6Publishing: 173] [Article Influence: 49.3] [Reference Citation Analysis]
141 Spizzo R, Nicoloso MS, Calin GA. MicroRNAs as new biomarkers in oncology. Expert Opin Med Diagn 2008;2:115-27. [PMID: 23485132 DOI: 10.1517/17530059.2.2.115] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
142 Cheung O, Sanyal AJ. MicroRNAs. In: Dufour J, Clavien P, editors. Signaling Pathways in Liver Diseases. Berlin: Springer Berlin Heidelberg; 2010. pp. 493-9. [DOI: 10.1007/978-3-642-00150-5_33] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Condorelli G, Latronico MV, Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol. 2014;63:2177-2187. [PMID: 24583309 DOI: 10.1016/j.jacc.2014.01.050] [Cited by in Crossref: 234] [Cited by in F6Publishing: 210] [Article Influence: 29.3] [Reference Citation Analysis]
144 Tay HL, Plank M, Collison A, Mattes J, Kumar RK, Foster PS. MicroRNA: potential biomarkers and therapeutic targets for allergic asthma? Ann Med 2014;46:633-9. [PMID: 25307360 DOI: 10.3109/07853890.2014.958196] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
145 Shim U, Kim HN, Sung YA, Kim HL. Pathway Analysis of Metabolic Syndrome Using a Genome-Wide Association Study of Korea Associated Resource (KARE) Cohorts. Genomics Inform 2014;12:195-202. [PMID: 25705158 DOI: 10.5808/GI.2014.12.4.195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
146 Love TM, Moffett HF, Novina CD. Not miR-ly small RNAs: big potential for microRNAs in therapy. J Allergy Clin Immunol 2008;121:309-19. [PMID: 18269923 DOI: 10.1016/j.jaci.2007.12.1167] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
147 Miao Z, Wang S, Wang Y, Wei P, Khan MA, Zhang J, Guo L, Liu D. Comparison of microRNAs in the intramuscular adipose tissue from Jinhua and Landrace pigs. J Cell Biochem 2019;120:192-200. [DOI: 10.1002/jcb.27298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
148 Li YY. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(45): 6546-6551 [PMID: 23236228 DOI: 10.3748/wjg.v18.i45.6546] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
149 Zhang B, Farwell MA. microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 2008;12:3-21. [PMID: 18088390 DOI: 10.1111/j.1582-4934.2007.00196.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 5.9] [Reference Citation Analysis]
150 Spizzo R, Rushworth D, Guerrero M, Calin GA. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. Clin Lymphoma Myeloma 2009;9 Suppl 3:S313-8. [PMID: 19778859 DOI: 10.3816/CLM.2009.s.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
151 Xie J, Ameres SL, Friedline R, Hung JH, Zhang Y, Xie Q, Zhong L, Su Q, He R, Li M, Li H, Mu X, Zhang H, Broderick JA, Kim JK, Weng Z, Flotte TR, Zamore PD, Gao G. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat Methods 2012;9:403-9. [PMID: 22388288 DOI: 10.1038/nmeth.1903] [Cited by in Crossref: 140] [Cited by in F6Publishing: 139] [Article Influence: 14.0] [Reference Citation Analysis]
152 Alvarez ML, Khosroheidari M, Eddy E, Done SC. MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis. Atherosclerosis 2015;242:595-604. [PMID: 26318398 DOI: 10.1016/j.atherosclerosis.2015.08.023] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
153 Fiorino S, Lorenzini S, Masetti M, Deleonardi G, Grondona AG, Silvestri T, Chili E, Del Prete P, Bacchi-Reggiani L, Cuppini A. Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma. Med Hypotheses. 2012;79:678-697. [PMID: 22959312 DOI: 10.1016/j.mehy.2012.08.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
154 Lee TH, Matta B, King BD, Hodges MR, Tillmann HL, Patel K. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection. J Med Virol 2015;87:1722-6. [PMID: 25963774 DOI: 10.1002/jmv.24230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
155 Momi N, Kaur S, Rachagani S, Ganti AK, Batra SK. Smoking and microRNA dysregulation: a cancerous combination. Trends Mol Med 2014;20:36-47. [PMID: 24238736 DOI: 10.1016/j.molmed.2013.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
156 Horwich MD, Zamore PD. Design and delivery of antisense oligonucleotides to block microRNA function in cultured Drosophila and human cells. Nat Protoc 2008;3:1537-49. [PMID: 18802435 DOI: 10.1038/nprot.2008.145] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 5.2] [Reference Citation Analysis]
157 Afonso MB, Rodrigues PM, Simão AL, Castro RE. Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. J Clin Med 2016;5:E30. [PMID: 26950158 DOI: 10.3390/jcm5030030] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 8.5] [Reference Citation Analysis]
158 Topkara VK, Mann DL. Clinical applications of miRNAs in cardiac remodeling and heart failure. Per Med 2010;7:531-48. [PMID: 21399714 DOI: 10.2217/pme.10.44] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
159 Koufaris C, Wright J, Osborne M, Currie RA, Gooderham NJ. Time and dose-dependent effects of phenobarbital on the rat liver miRNAome. Toxicology 2013;314:247-53. [PMID: 24157574 DOI: 10.1016/j.tox.2013.10.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
160 Chen JF, Callis TE, Wang DZ. microRNAs and muscle disorders. J Cell Sci. 2009;122:13-20. [PMID: 19092056 DOI: 10.1242/jcs.041723] [Cited by in Crossref: 102] [Cited by in F6Publishing: 99] [Article Influence: 7.8] [Reference Citation Analysis]
161 Rogler CE. MicroRNAs Make Inroads Into Liver Development. Gastroenterology 2009;136:770-2. [DOI: 10.1053/j.gastro.2009.01.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
162 DeVos SL, Miller TM. Antisense oligonucleotides: treating neurodegeneration at the level of RNA. Neurotherapeutics 2013;10:486-97. [PMID: 23686823 DOI: 10.1007/s13311-013-0194-5] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 12.1] [Reference Citation Analysis]
163 Freeman LA. Cloning full-length transcripts and transcript variants using 5' and 3' RACE. Methods Mol Biol 2013;1027:3-17. [PMID: 23912980 DOI: 10.1007/978-1-60327-369-5_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
164 Ye J, Zou M, Li P, Liu H. MicroRNA Regulation of Energy Metabolism to Induce Chemoresistance in Cancers. Technol Cancer Res Treat 2018;17:1533033818805997. [PMID: 30444190 DOI: 10.1177/1533033818805997] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
165 Xie H, Sun L, Lodish HF. Targeting microRNAs in obesity. Expert Opin Ther Targets 2009;13:1227-38. [PMID: 19650761 DOI: 10.1517/14728220903190707] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
166 Chen XM. MicroRNA signatures in liver diseases. World J Gastroenterol 2009; 15(14): 1665-1672 [PMID: 19360909 DOI: 10.3748/wjg.15.1665] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 86] [Article Influence: 6.6] [Reference Citation Analysis]
167 Berezhna SY, Supekova L, Sever MJ, Schultz PG, Deniz AA. Dual regulation of hepatitis C viral RNA by cellular RNAi requires partitioning of Ago2 to lipid droplets and P-bodies. RNA 2011;17:1831-45. [PMID: 21868483 DOI: 10.1261/rna.2523911] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
168 Elkhodiry AA, El Tayebi HM. Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis. Noncoding RNA Res 2021;6:187-99. [PMID: 34938929 DOI: 10.1016/j.ncrna.2021.12.002] [Reference Citation Analysis]
169 Ohlsson Teague EMC, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Human Reproduction Update 2010;16:142-65. [DOI: 10.1093/humupd/dmp034] [Cited by in Crossref: 177] [Cited by in F6Publishing: 175] [Article Influence: 13.6] [Reference Citation Analysis]
170 Aravalli RN. Development of microRNA therapeutics for hepatocellular carcinoma. Diagnostics. 2013;3:170-191. [PMID: 26835673 DOI: 10.3390/diagnostics3010170] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
171 Björkgren I, Gylling H, Turunen H, Huhtaniemi I, Strauss L, Poutanen M, Sipilä P. Imbalanced lipid homeostasis in the conditional Dicer1 knockout mouse epididymis causes instability of the sperm membrane. FASEB j 2014;29:433-42. [DOI: 10.1096/fj.14-259382] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
172 Watts JK, Corey DR. Silencing disease genes in the laboratory and the clinic. J Pathol. 2012;226:365-379. [PMID: 22069063 DOI: 10.1002/path.2993] [Cited by in Crossref: 243] [Cited by in F6Publishing: 222] [Article Influence: 22.1] [Reference Citation Analysis]
173 Zhang C, Qiao S, Wu J, Xu W, Ma S, Zhao B, Wang X. A new insulin-sensitive enhancer from Silene viscidula, WPTS, treats type 2 diabetes by ameliorating insulin resistance, reducing dyslipidemia, and promoting proliferation of islet β cells. Pharmacol Res 2021;165:105416. [PMID: 33412277 DOI: 10.1016/j.phrs.2020.105416] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Shafi G, Aliya N, Munshi A. MicroRNA signatures in neurological disorders. Can J Neurol Sci 2010;37:177-85. [PMID: 20437927 DOI: 10.1017/s0317167100009902] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
175 Sharapova T, Devanarayan V, Leroy B, Liguori MJ, Blomme E, Buck W, Maher J. Evaluation of miR-122 as a Serum Biomarker for Hepatotoxicity in Investigative Rat Toxicology Studies. Vet Pathol 2016;53:211-21. [DOI: 10.1177/0300985815591076] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
176 Ceccarelli S, Nobili V, Alisi A. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. World J Gastroenterol. 2014;20:16443-16451. [PMID: 25469012 DOI: 0.3748/wjg.v20.i44.16443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 O’Neill SM, Hinkle C, Chen SJ, Sandhu A, Hovhannisyan R, Stephan S, Lagor WR, Ahima RS, Johnston JC, Reilly MP. Targeting adipose tissue via systemic gene therapy. Gene Ther. 2014;21:653-661. [PMID: 24830434 DOI: 10.1038/gt.2014.38] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
178 Hou W, Bonkovsky HL. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: Dysregulation and implications for early detection, diagnosis and therapy. World J Gastroenterol 2013; 19(44): 7836-7845 [PMID: 24307777 DOI: 10.3748/wjg.v19.i44.7836] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
179 Witkos TM, Koscianska E, Krzyzosiak WJ. Practical Aspects of microRNA Target Prediction. Curr Mol Med 2011;11:93-109. [PMID: 21342132 DOI: 10.2174/156652411794859250] [Cited by in Crossref: 315] [Cited by in F6Publishing: 291] [Article Influence: 28.6] [Reference Citation Analysis]
180 Mao Y, Mohan R, Zhang S, Tang X. MicroRNAs as pharmacological targets in diabetes. Pharmacol Res 2013;75:37-47. [PMID: 23810798 DOI: 10.1016/j.phrs.2013.06.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
181 Chandrasekaran K, Karolina DS, Sepramaniam S, Armugam A, Wintour EM, Bertram JF, Jeyaseelan K. Role of microRNAs in kidney homeostasis and disease. Kidney Int. 2012;81:617-627. [PMID: 22237749 DOI: 10.1038/ki.2011.448] [Cited by in Crossref: 147] [Cited by in F6Publishing: 140] [Article Influence: 14.7] [Reference Citation Analysis]
182 Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S. Inhibition of microRNA function by antimiR oligonucleotides. Silence. 2012;3:1. [PMID: 22230293 DOI: 10.1186/1758-907x-3-1] [Cited by in Crossref: 333] [Cited by in F6Publishing: 199] [Article Influence: 33.3] [Reference Citation Analysis]
183 Dong J, Liang YZ, Zhang J, Wu LJ, Wang S, Hua Q, Yan YX. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease. J Atheroscler Thromb 2017;24:430-41. [PMID: 27629254 DOI: 10.5551/jat.35923] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
184 Li T, Zhu L, Zhu L, Wang P, Xu W, Huang J. Recent Developments in Delivery of MicroRNAs Utilizing Nanosystems for Metabolic Syndrome Therapy. Int J Mol Sci 2021;22:7855. [PMID: 34360621 DOI: 10.3390/ijms22157855] [Reference Citation Analysis]
185 Hartig SM, Hamilton MP, Bader DA, McGuire SE. The miRNA Interactome in Metabolic Homeostasis. Trends Endocrinol Metab 2015;26:733-45. [PMID: 26492831 DOI: 10.1016/j.tem.2015.09.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
186 Kilikevicius A, Meister G, Corey DR. Reexamining assumptions about miRNA-guided gene silencing. Nucleic Acids Res 2021:gkab1256. [PMID: 34967419 DOI: 10.1093/nar/gkab1256] [Reference Citation Analysis]
187 Dangwal S, Schimmel K, Foinquinos A, Xiao K, Thum T. Noncoding RNAs in Heart Failure. Handb Exp Pharmacol. 2017;243:423-445. [PMID: 27995387 DOI: 10.1007/164_2016_99] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
188 Kao CC, Yi G, Huang HC. The core of hepatitis C virus pathogenesis. Curr Opin Virol. 2016;17:66-73. [PMID: 26851516 DOI: 10.1016/j.coviro.2016.01.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
189 Hyrina A, Olmstead AD, Steven P, Krajden M, Tam E, Jean F. Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9. EBioMedicine 2017;23:68-78. [PMID: 28864162 DOI: 10.1016/j.ebiom.2017.08.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
190 Vinchi F. Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron. Antioxid Redox Signal 2021;35:387-414. [PMID: 33554718 DOI: 10.1089/ars.2020.8167] [Reference Citation Analysis]
191 Lardizábal MN, Rodríguez RE, Nocito AL, Daniele SM, Palatnik JF, Veggi LM. Alteration of the microRNA-122 regulatory network in rat models of hepatotoxicity. Environ Toxicol Pharmacol 2014;37:354-64. [PMID: 24388909 DOI: 10.1016/j.etap.2013.12.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
192 Aizawa Y, Seki N, Nagano T, Abe H. Chronic hepatitis C virus infection and lipoprotein metabolism. World J Gastroenterol 2015; 21(36): 10299-10313 [PMID: 26420957 DOI: 10.3748/wjg.v21.i36.10299] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
193 Deiuliis JA. MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes (Lond) 2016;40:88-101. [PMID: 26311337 DOI: 10.1038/ijo.2015.170] [Cited by in Crossref: 180] [Cited by in F6Publishing: 169] [Article Influence: 25.7] [Reference Citation Analysis]
194 Song Y, Wu L, Li M, Xiong X, Fang Z, Zhou J, Yan G, Chen X, Yang J, Li Y. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance. EBioMedicine 2019;42:494-503. [PMID: 30948354 DOI: 10.1016/j.ebiom.2019.03.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
195 Chartoumpekis DV, Zaravinos A, Ziros PG, Iskrenova RP, Psyrogiannis AI, Kyriazopoulou VE, Habeos IG. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One. 2012;7:e34872. [PMID: 22496873 DOI: 10.1371/journal.pone.0034872] [Cited by in Crossref: 157] [Cited by in F6Publishing: 143] [Article Influence: 15.7] [Reference Citation Analysis]
196 Paseban M, Butler AE, Sahebkar A. Mechanisms of statin‐induced new‐onset diabetes. J Cell Physiol 2019;234:12551-61. [DOI: 10.1002/jcp.28123] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
197 Lin X, Luo J, Zhang L, Wang W, Gou D. MiR-103 controls milk fat accumulation in goat (Capra hircus) mammary gland during lactation. PLoS One 2013;8:e79258. [PMID: 24244462 DOI: 10.1371/journal.pone.0079258] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
198 Seth PP, Swayze EE. Unnatural Nucleoside Analogs for Antisense Therapy. In: Hanessian S, editor. Natural Products in Medicinal Chemistry. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2014. pp. 403-40. [DOI: 10.1002/9783527676545.ch12] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
199 Pattullo V, Douglas MW, George J. Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis? Expert Rev Gastroenterol Hepatol 2011;5:265-77. [PMID: 21476921 DOI: 10.1586/egh.11.12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
200 Ishida M, Selaru FM. miRNA-Based Therapeutic Strategies. Curr Anesthesiol Rep 2013;1:63-70. [PMID: 23524956 DOI: 10.1007/s40139-012-0004-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
201 Arora S, Patra SK, Saini R. HDL—A molecule with a multi-faceted role in coronary artery disease. Clinica Chimica Acta 2016;452:66-81. [DOI: 10.1016/j.cca.2015.10.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
202 Barwari T, Joshi A, Mayr M. MicroRNAs in Cardiovascular Disease. J Am Coll Cardiol 2016;68:2577-84. [PMID: 27931616 DOI: 10.1016/j.jacc.2016.09.945] [Cited by in Crossref: 170] [Cited by in F6Publishing: 163] [Article Influence: 34.0] [Reference Citation Analysis]
203 Chen XM. MicroRNA signatures in liver diseases. World J Gastroenterol. 2009;15:1665-1672. [PMID: 19360909 DOI: 10.3748/wjg.15.1665;] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Wang X, Yang L, Wang H, Shao F, Yu J, Jiang H, Han Y, Gong D, Gu Z. Growth hormone-regulated mRNAs and miRNAs in chicken hepatocytes. PLoS One 2014;9:e112896. [PMID: 25386791 DOI: 10.1371/journal.pone.0112896] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
205 Dolganiuc A, Petrasek J, Kodys K, Catalano D, Mandrekar P, Velayudham A, Szabo G. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res. 2009;33:1704-1710. [PMID: 19572984 DOI: 10.1111/j.1530-0277.2009.01007.x] [Cited by in Crossref: 135] [Cited by in F6Publishing: 127] [Article Influence: 10.4] [Reference Citation Analysis]
206 Xu Y, Zhu S, Liu F, Wang W, Wang X, Han G, Cheng B. Identification of Arbuscular Mycorrhiza Fungi Responsive microRNAs and Their Regulatory Network in Maize. Int J Mol Sci 2018;19:E3201. [PMID: 30332850 DOI: 10.3390/ijms19103201] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
207 Moens U. Silencing viral microRNA as a novel antiviral therapy? J Biomed Biotechnol 2009;2009:419539. [PMID: 19704916 DOI: 10.1155/2009/419539] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
208 Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O, Fleury-Olela F, Ruskeepää AL, Oresic M, Esau CC, Zdobnov EM. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev. 2009;23:1313-1326. [PMID: 19487572 DOI: 10.1101/gad.1781009] [Cited by in Crossref: 270] [Cited by in F6Publishing: 258] [Article Influence: 20.8] [Reference Citation Analysis]
209 Lai CY, Lin CY, Hsu CC, Yeh KY, Her GM. Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish. Biochim Biophys Acta Mol Cell Biol Lipids 2018;1863:844-56. [PMID: 29678641 DOI: 10.1016/j.bbalip.2018.04.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
210 Poy MN, Spranger M, Stoffel M. microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab 2007;9 Suppl 2:67-73. [PMID: 17919180 DOI: 10.1111/j.1463-1326.2007.00775.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 7.6] [Reference Citation Analysis]
211 Kurtz CL, Fannin EE, Toth CL, Pearson DS, Vickers KC, Sethupathy P. Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver. Sci Rep 2015;5:12911. [PMID: 26246194 DOI: 10.1038/srep12911] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
212 Das A, Basu S, Bandyopadhyay D, Mukherjee K, Datta D, Chakraborty S, Jana S, Adak M, Bose S, Chakrabarti S, Swarnakar S, Chakrabarti P, Bhattacharyya SN. Inhibition of extracellular vesicle-associated MMP2 abrogates intercellular hepatic miR-122 transfer to liver macrophages and curtails inflammation. iScience 2021;24:103428. [PMID: 34877493 DOI: 10.1016/j.isci.2021.103428] [Reference Citation Analysis]
213 Baselga-Escudero L, Bladé C, Ribas-Latre A, Casanova E, Salvadó MJ, Arola L, Arola-Arnal A. Grape seed proanthocyanidins repress the hepatic lipid regulators miR-33 and miR-122 in rats. Mol Nutr Food Res. 2012;56:1636-1646. [PMID: 22965541 DOI: 10.1002/mnfr.201200237] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 6.9] [Reference Citation Analysis]
214 Tu W, You L, Tsou A, Chen C. Pten Haplodeficiency Accelerates Liver Tumor Growth in miR-122a–Null Mice via Expansion of Periportal Hepatocyte-Like Cells. The American Journal of Pathology 2018;188:2688-702. [DOI: 10.1016/j.ajpath.2018.07.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
215 Liang Y, Wang Y, Ma L, Zhong Z, Yang X, Tao X, Chen X, He Z, Yang Y, Zeng K, Kang R, Gong J, Ying S, Lei Y, Pang J, Lv X, Gu Y. Comparison of microRNAs in adipose and muscle tissue from seven indigenous Chinese breeds and Yorkshire pigs. Anim Genet 2019;50:439-48. [PMID: 31328299 DOI: 10.1111/age.12826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
216 Jackson AL, Levin AA. Developing microRNA therapeutics: approaching the unique complexities. Nucleic Acid Ther 2012;22:213-25. [PMID: 22913594 DOI: 10.1089/nat.2012.0356] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
217 Jopling CL. Targeting microRNA-122 to Treat Hepatitis C Virus Infection. Viruses 2010;2:1382-93. [PMID: 21994685 DOI: 10.3390/v2071382] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
218 Zhang DD, Wang DD, Wang Z, Wang YB, Li GX, Sun GR, Tian YD, Han RL, Li ZJ, Jiang RR, Liu XJ, Kang XT, Li H. Estrogen Abolishes the Repression Role of gga-miR-221-5p Targeting ELOVL6 and SQLE to Promote Lipid Synthesis in Chicken Liver. Int J Mol Sci 2020;21:E1624. [PMID: 32120850 DOI: 10.3390/ijms21051624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
219 Flowers E, Froelicher ES, Aouizerat BE. MicroRNA regulation of lipid metabolism. Metabolism 2013;62:12-20. [PMID: 22607769 DOI: 10.1016/j.metabol.2012.04.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
220 Redis RS, Berindan-Neagoe I, Pop VI, Calin GA. Non-coding RNAs as theranostics in human cancers. J Cell Biochem. 2012;113:1451-1459. [PMID: 22213511 DOI: 10.1002/jcb.24038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
221 Motawi TMK, Sadik NAH, Shaker OG, Ghaleb MH. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer. Tumor Biol 2016;37:9865-74. [DOI: 10.1007/s13277-016-4884-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
222 Durso M, Gaglione M, Piras L, Mercurio ME, Terreri S, Olivieri M, Marinelli L, Novellino E, Incoronato M, Grieco P, Orsini G, Tonon G, Messere A, Cimmino A. Chemical modifications in the seed region of miRNAs 221/222 increase the silencing performances in gastrointestinal stromal tumor cells. Eur J Med Chem. 2016;111:15-25. [PMID: 26854374 DOI: 10.1016/j.ejmech.2016.01.047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
223 Wang X, Shao F, Yu J, Jiang H, Gong D, Gu Z. MicroRNA-122 targets genes related to liver metabolism in chickens. Comp Biochem Physiol B Biochem Mol Biol 2015;184:29-35. [PMID: 25711929 DOI: 10.1016/j.cbpb.2015.02.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
224 Thibault PA, Wilson JA. Transient replication of Hepatitis C Virus sub-genomic RNA in murine cell lines is enabled by miR-122 and varies with cell passage. PLoS One 2014;9:e89971. [PMID: 24587159 DOI: 10.1371/journal.pone.0089971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
225 Check JH. Serum CA 125 levels in early pregnancy and subsequent spontaneous abortion. Obstet Gynecol. 1990;76:894-895. [PMID: 2216246 DOI: 10.1002/emmm.201100191] [Cited by in Crossref: 131] [Cited by in F6Publishing: 125] [Article Influence: 4.1] [Reference Citation Analysis]
226 Lau K, Lai KP, Bao JY, Zhang N, Tse A, Tong A, Li JW, Lok S, Kong RY, Lui WY, Wong A, Wu RS. Identification and expression profiling of microRNAs in the brain, liver and gonads of marine medaka (Oryzias melastigma) and in response to hypoxia. PLoS One 2014;9:e110698. [PMID: 25350659 DOI: 10.1371/journal.pone.0110698] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
227 Shi MA, Shi GP. Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseases. Sci Signal. 2010;3:pe40. [PMID: 21045204 DOI: 10.1126/scisignal.3146pe40] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
228 Zhao E, Keller MP, Rabaglia ME, Oler AT, Stapleton DS, Schueler KL, Neto EC, Moon JY, Wang P, Wang IM. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm Genome. 2009;20:476-485. [PMID: 19727952 DOI: 10.1007/00335-009-9217-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
229 Christian P, Su Q. MicroRNA regulation of mitochondrial and ER stress signaling pathways: implications for lipoprotein metabolism in metabolic syndrome. Am J Physiol Endocrinol Metab 2014;307:E729-37. [PMID: 25184990 DOI: 10.1152/ajpendo.00194.2014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
230 Neudecker V, Brodsky KS, Kreth S, Ginde AA, Eltzschig HK. Emerging Roles for MicroRNAs in Perioperative Medicine. Anesthesiology 2016;124:489-506. [PMID: 26632665 DOI: 10.1097/ALN.0000000000000969] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
231 Rayner KJ, Moore KJ. The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis. Curr Atheroscler Rep 2012;14:413-21. [PMID: 22847770 DOI: 10.1007/s11883-012-0272-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
232 Manzano-román R, Siles-lucas M. MicroRNAs in parasitic diseases: Potential for diagnosis and targeting. Molecular and Biochemical Parasitology 2012;186:81-6. [DOI: 10.1016/j.molbiopara.2012.10.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 5.2] [Reference Citation Analysis]
233 Chu M, Zhao Y, Yu S, Hao Y, Zhang P, Feng Y, Zhang H, Ma D, Liu J, Cheng M, Li L, Shen W, Cao H, Li Q, Min L. MicroRNA-221 may be involved in lipid metabolism in mammary epithelial cells. Int J Biochem Cell Biol 2018;97:118-27. [PMID: 29474925 DOI: 10.1016/j.biocel.2018.02.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
234 Dhir A, Dhir S, Proudfoot NJ, Jopling CL. Microprocessor mediates transcriptional termination of long noncoding RNA transcripts hosting microRNAs. Nat Struct Mol Biol 2015;22:319-27. [PMID: 25730776 DOI: 10.1038/nsmb.2982] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 11.3] [Reference Citation Analysis]
235 Zhang W, Wang T, Su Y, Li W, Frame LT, Ai G. Recombinant adenoviral microRNA-206 induces myogenesis in C2C12 cells. Med Sci Monit 2011;17:BR364-71. [PMID: 22129894 DOI: 10.12659/msm.882122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
236 Meale SJ, Romao JM, He ML, Chaves AV, McAllister TA, Guan LL. Effect of diet on microRNA expression in ovine subcutaneous and visceral adipose tissues. J Anim Sci 2014;92:3328-37. [PMID: 24893997 DOI: 10.2527/jas.2014-7710] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
237 Hemida MG, Ye X, Thair S, Yang D. Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations. Mol Diagn Ther 2010;14:271-82. [PMID: 21053993 DOI: 10.1007/BF03256383] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
238 Torres AG, Threlfall RN, Gait MJ. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents. Artif DNA PNA XNA 2011;2:71-8. [PMID: 22567190 DOI: 10.4161/adna.17731] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
239 Lu RH, Qin CB, Yang F, Zhang WY, Zhang YR, Yang GK, Yang LP, Meng XL, Yan X, Nie GX. Grape seed proanthocyanidin extract ameliorates hepatic lipid accumulation and inflammation in grass carp (Ctenopharyngodon idella). Fish Physiol Biochem 2020;46:1665-77. [PMID: 32447624 DOI: 10.1007/s10695-020-00819-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
240 Kiamehr M, Heiskanen L, Laufer T, Düsterloh A, Kahraman M, Käkelä R, Laaksonen R, Aalto-Setälä K. Dedifferentiation of Primary Hepatocytes is Accompanied with Reorganization of Lipid Metabolism Indicated by Altered Molecular Lipid and miRNA Profiles. Int J Mol Sci 2019;20:E2910. [PMID: 31207892 DOI: 10.3390/ijms20122910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
241 Chen YH, Heneidi S, Lee JM, Layman LC, Stepp DW, Gamboa GM, Chen BS, Chazenbalk G, Azziz R. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes. 2013;62:2278-2286. [PMID: 23493574 DOI: 10.2337/db12-0963] [Cited by in Crossref: 144] [Cited by in F6Publishing: 140] [Article Influence: 16.0] [Reference Citation Analysis]
242 DiMarco DM, Fernandez ML. The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs. Biology (Basel) 2015;4:494-511. [PMID: 26226008 DOI: 10.3390/biology4030494] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
243 Rotllan N, Price N, Pati P, Goedeke L, Fernández-Hernando C. microRNAs in lipoprotein metabolism and cardiometabolic disorders. Atherosclerosis 2016;246:352-60. [PMID: 26828754 DOI: 10.1016/j.atherosclerosis.2016.01.025] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 11.2] [Reference Citation Analysis]
244 Pager CT, Wehner KA, Fuchs G, Sarnow P. MicroRNA-mediated gene silencing. Prog Mol Biol Transl Sci. 2009;90:187-210. [PMID: 20374742 DOI: 10.1016/S1877-1173(09)90005-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
245 Willeit P, Skroblin P, Moschen AR, Yin X, Kaudewitz D, Zampetaki A, Barwari T, Whitehead M, Ramírez CM, Goedeke L, Rotllan N, Bonora E, Hughes AD, Santer P, Fernández-Hernando C, Tilg H, Willeit J, Kiechl S, Mayr M. Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes. Diabetes 2017;66:347-57. [PMID: 27899485 DOI: 10.2337/db16-0731] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 18.7] [Reference Citation Analysis]
246 Sriramoju B, Kanwar RK, Kanwar JR. Lactoferrin induced neuronal differentiation: A boon for brain tumours. Int j dev neurosci 2015;41:28-36. [DOI: 10.1016/j.ijdevneu.2014.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
247 Guennewig B, Stoltz M, Menzi M, Dogar AM, Hall J. Properties of N(4)-methylated cytidines in miRNA mimics. Nucleic Acid Ther 2012;22:109-16. [PMID: 22373008 DOI: 10.1089/nat.2011.0329] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
248 Zhang WW, Sun XF, Tong HL, Wang YH, Li SF, Yan YQ, Li GP. Effect of differentiation on microRNA expression in bovine skeletal muscle satellite cells by deep sequencing. Cell Mol Biol Lett 2016;21:8. [PMID: 28536611 DOI: 10.1186/s11658-016-0009-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
249 Wang YL, Yu W. Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions. PeerJ 2018;6:e5218. [PMID: 30013851 DOI: 10.7717/peerj.5218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
250 Akbari Kordkheyli V, Khonakdar Tarsi A, Mishan MA, Tafazoli A, Bardania H, Zarpou S, Bagheri A. Effects of quercetin on microRNAs: A mechanistic review. J Cell Biochem 2019;120:12141-55. [PMID: 30957271 DOI: 10.1002/jcb.28663] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
251 Horst AK, Kumashie KG, Neumann K, Diehl L, Tiegs G. Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease. Cell Mol Immunol 2021;18:92-111. [PMID: 33110250 DOI: 10.1038/s41423-020-00568-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
252 Nelson PE, Surzycki SJ. Characterization of the oxygenase activity in a mutant of Chlamydomonas reinhardi exhibiting altered ribulosebisphosphate carboxylase. Eur J Biochem 1976;61:475-80. [PMID: 2467 DOI: 10.1111/j.1432-1033.1976.tb10041.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
253 Wu D, Xi QY, Cheng X, Dong T, Zhu XT, Shu G, Wang LN, Jiang QY, Zhang YL. miR-146a-5p inhibits TNF-α-induced adipogenesis via targeting insulin receptor in primary porcine adipocytes. J Lipid Res 2016;57:1360-72. [PMID: 27324794 DOI: 10.1194/jlr.M062497] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
254 Shyu YC, Lee TL, Lu MJ, Chen JR, Chien RN, Chen HY, Lin JF, Tsou AP, Chen YH, Hsieh CW, Huang TS. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma. J Transl Med 2016;14:200. [PMID: 27370270 DOI: 10.1186/s12967-016-0956-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
255 Lindow M, Kauppinen S. Discovering the first microRNA-targeted drug. J Cell Biol. 2012;199:407-412. [PMID: 23109665 DOI: 10.1083/jcb.201208082] [Cited by in Crossref: 183] [Cited by in F6Publishing: 167] [Article Influence: 20.3] [Reference Citation Analysis]
256 Fu H, Zhang X, Wang Q, Sun Y, Liu L, Huang L, Ding L, Shen M, Zhang L, Duan Y. Simple and rational design of a polymer nano-platform for high performance of HCV related miR-122 reduction in the liver. Biomater Sci 2018;6:2667-80. [PMID: 30209483 DOI: 10.1039/c8bm00639c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
257 Dallio M, Romeo M, Gravina AG, Masarone M, Larussa T, Abenavoli L, Persico M, Loguercio C, Federico A. Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients 2021;13:1679. [PMID: 34063372 DOI: 10.3390/nu13051679] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Jopling CL, Schütz S, Sarnow P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe. 2008;4:77-85. [PMID: 18621012 DOI: 10.1016/j.chom.2008. 05.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
259 Haussecker D, Kay MA. miR-122 continues to blaze the trail for microRNA therapeutics. Mol Ther 2010;18:240-2. [PMID: 20125164 DOI: 10.1038/mt.2009.313] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
260 Masotti A, Baldassarre A, Fabrizi M, Olivero G, Loreti MC, Giammaria P, Veronelli P, Graziani MP, Manco M. Oral glucose tolerance test unravels circulating miRNAs associated with insulin resistance in obese preschoolers: miRNAs and insulin resistance. Pediatric Obesity 2017;12:229-38. [DOI: 10.1111/ijpo.12133] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
261 Gong Y, Lyu W, Shi X, Zou X, Lu L, Yang H, Xiao Y. A Serum Metabolic Profiling Analysis During the Formation of Fatty Liver in Landes Geese via GC-TOF/MS. Front Physiol 2020;11:581699. [PMID: 33381050 DOI: 10.3389/fphys.2020.581699] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
262 Zisoulis DG. Quantification of Oligonucleotide Association with miRNA-Argonaute Complexes In Vitro. Methods Mol Biol 2017;1517:71-8. [PMID: 27924474 DOI: 10.1007/978-1-4939-6563-2_4] [Reference Citation Analysis]
263 Jonstrup SP, Koch J, Kjems J. A microRNA detection system based on padlock probes and rolling circle amplification. RNA 2006;12:1747-52. [PMID: 16888321 DOI: 10.1261/rna.110706] [Cited by in Crossref: 164] [Cited by in F6Publishing: 151] [Article Influence: 10.3] [Reference Citation Analysis]
264 Li C, Lu L, Qi Z, Zhu Y, Su F, Zhao P, Dong H. Transcriptome and miRNome Analysis Provide New Insight Into Host Lipid Accumulation, Innate Immunity, and Viral Persistence in Hepatitis C Virus Infection in vitro. Front Microbiol 2020;11:535673. [PMID: 33101221 DOI: 10.3389/fmicb.2020.535673] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
265 Shea CM, Tzertzinis G. Controlled expression of functional miR-122 with a ligand inducible expression system. BMC Biotechnol 2010;10:76. [PMID: 20961424 DOI: 10.1186/1472-6750-10-76] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
266 Vega-badillo J. ALTERACIONES EN LA HOMEOSTASIS DEL COLESTEROL HEPÁTICO Y SUS IMPLICACIONES EN LA ESTEATOHEPATITIS NO ALCOHÓLICA. TIP 2017;20:50-65. [DOI: 10.1016/j.recqb.2016.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
267 Cao T, Zhen XC. Dysregulation of miRNA and its potential therapeutic application in schizophrenia. CNS Neurosci Ther 2018;24:586-97. [PMID: 29529357 DOI: 10.1111/cns.12840] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
268 Nasheri N, Cheng J, Singaravelu R, Wu P, Mcdermott MT, Pezacki JP. An enzyme-linked assay for the rapid quantification of microRNAs based on the viral suppressor of RNA silencing protein p19. Analytical Biochemistry 2011;412:165-72. [DOI: 10.1016/j.ab.2011.01.030] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
269 Kornmueller K, Amri E, Scheideler M, Prassl R. Delivery of miRNAs to the adipose organ for metabolic health. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2021.114110] [Reference Citation Analysis]
270 Curtin CM, Castaño IM, O'Brien FJ. Scaffold-Based microRNA Therapies in Regenerative Medicine and Cancer. Adv Healthc Mater 2018;7. [PMID: 29068566 DOI: 10.1002/adhm.201700695] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
271 Yang M, Mattes J. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol Ther 2008;117:94-104. [PMID: 17928059 DOI: 10.1016/j.pharmthera.2007.08.004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
272 Gómez-Hernández A, de Las Heras N, López-Pastor AR, García-Gómez G, Infante-Menéndez J, González-López P, González-Illanes T, Lahera V, Benito M, Escribano Ó. Severe Hepatic Insulin Resistance Induces Vascular Dysfunction: Improvement by Liver-Specific Insulin Receptor Isoform A Gene Therapy in a Murine Diabetic Model. Cells 2021;10:2035. [PMID: 34440804 DOI: 10.3390/cells10082035] [Reference Citation Analysis]
273 Peng F, Xiao X, Jiang Y, Luo K, Tian Y, Peng M, Zhang M, Xu Y, Gong G. HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122. PLoS One. 2014;9:e92998. [PMID: 24667324 DOI: 10.1371/journal.pone.0092998] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
274 Ghelani HS, Rachchh MA, Gokani RH. MicroRNAs as newer therapeutic targets: A big hope from a tiny player. J Pharmacol Pharmacother. 2012;3:217-227. [PMID: 23129956 DOI: 10.4103/0976-500x.99416] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
275 Gadecka A, Bielak-Zmijewska A. Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome. Nutrients 2019;11:E1251. [PMID: 31159371 DOI: 10.3390/nu11061251] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
276 Crooke RM, Graham MJ. Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia. Clinical Lipidology 2011;6:675-92. [DOI: 10.2217/clp.11.59] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
277 Du NH, Arpat AB, De Matos M, Gatfield D. MicroRNAs shape circadian hepatic gene expression on a transcriptome-wide scale. Elife 2014;3:e02510. [PMID: 24867642 DOI: 10.7554/eLife.02510] [Cited by in Crossref: 64] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
278 Yu AM, Pan YZ. Noncoding microRNAs: small RNAs play a big role in regulation of ADME? Acta Pharm Sin B 2012;2:93-101. [PMID: 32154096 DOI: 10.1016/j.apsb.2012.02.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
279 Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2010;11:537-561. [PMID: 21532838 DOI: 10.2174/138920210793175895] [Cited by in Crossref: 815] [Cited by in F6Publishing: 771] [Article Influence: 74.1] [Reference Citation Analysis]
280 Yang J, Li C, Zhang L, Wang X. Extracellular Vesicles as Carriers of Non-coding RNAs in Liver Diseases. Front Pharmacol. 2018;9:415. [PMID: 29740327 DOI: 10.3389/fphar.2018.00415] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
281 Liu S, Wu Z, Guo S, Meng X, Chang X. Polyphenol-rich extract from wild Lonicera caerulea berry reduces cholesterol accumulation by mediating the expression of hepatic miR-33 and miR-122, HMGCR, and CYP7A1 in rats. Journal of Functional Foods 2018;40:648-58. [DOI: 10.1016/j.jff.2017.11.048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
282 Akerblom M, Sachdeva R, Jakobsson J. Functional Studies of microRNAs in Neural Stem Cells: Problems and Perspectives. Front Neurosci 2012;6:14. [PMID: 22347160 DOI: 10.3389/fnins.2012.00014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
283 van der Meer AJ, Farid WR, Sonneveld MJ, de Ruiter PE, Boonstra A, van Vuuren AJ, Verheij J, Hansen BE, de Knegt RJ, van der Laan LJ, Janssen HL. Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122. J Viral Hepat 2013;20:158-66. [PMID: 23383654 DOI: 10.1111/jvh.12001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
284 Citrin KM, Fernández-Hernando C, Suárez Y. MicroRNA regulation of cholesterol metabolism. Ann N Y Acad Sci 2021;1495:55-77. [PMID: 33521946 DOI: 10.1111/nyas.14566] [Reference Citation Analysis]
285 Ge S, Wang X, Xie J, Yi X, Liu F. Deep sequencing analysis of microRNA expression in porcine serum-induced hepatic fibrosis rats. Annals of Hepatology 2014;13:439-49. [DOI: 10.1016/s1665-2681(19)30851-8] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
286 Leelahavanichkul A, Somparn P, Panich T, Chancharoenthana W, Wongphom J, Pisitkun T, Hirankarn N, Eiam-Ong S. Serum miRNA-122 in acute liver injury induced by kidney injury and sepsis in CD-1 mouse models. Hepatol Res 2015;45:1341-52. [PMID: 25655304 DOI: 10.1111/hepr.12501] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
287 Ramnani P, Gao Y, Ozsoz M, Mulchandani A. Electronic detection of microRNA at attomolar level with high specificity. Anal Chem 2013;85:8061-4. [PMID: 23909395 DOI: 10.1021/ac4018346] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
288 Bouhaddioui W, Provost PR, Tremblay Y. Expression profile of androgen-modulated microRNAs in the fetal murine lung. Biol Sex Differ 2016;7:20. [PMID: 27042289 DOI: 10.1186/s13293-016-0072-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
289 Vienberg S, Geiger J, Madsen S, Dalgaard LT. MicroRNAs in metabolism. Acta Physiol (Oxf). 2017;219:346-361. [PMID: 27009502 DOI: 10.1111/apha.12681] [Cited by in Crossref: 169] [Cited by in F6Publishing: 159] [Article Influence: 28.2] [Reference Citation Analysis]
290 Sarnow P, Jopling CL, Norman KL, Schütz S, Wehner KA. MicroRNAs: expression, avoidance and subversion by vertebrate viruses. Nat Rev Microbiol. 2006;4:651-659. [PMID: 16912711 DOI: 10.1038/nrmicro1473] [Cited by in Crossref: 82] [Cited by in F6Publishing: 88] [Article Influence: 5.1] [Reference Citation Analysis]
291 Czech MP, Aouadi M, Tesz GJ. RNAi-based therapeutic strategies for metabolic disease. Nat Rev Endocrinol 2011;7:473-84. [PMID: 21502982 DOI: 10.1038/nrendo.2011.57] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.2] [Reference Citation Analysis]
292 Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133:647-658. [PMID: 17681183 DOI: 10.1053/j.gastro.2007.05.022] [Cited by in Crossref: 1863] [Cited by in F6Publishing: 1805] [Article Influence: 124.2] [Reference Citation Analysis]
293 Fu T, Kemper JK. MicroRNA-34a and Impaired FGF19/21 Signaling in Obesity. Vitam Horm 2016;101:175-96. [PMID: 27125742 DOI: 10.1016/bs.vh.2016.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
294 Cui A, Hu Z, Han Y, Yang Y, Li Y. Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis. J Vis Exp 2017. [PMID: 28362401 DOI: 10.3791/55178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
295 Chen SL, Zheng MH, Shi KQ, Yang T, Chen YP. A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job. BioDrugs. 2013;27:25-34. [PMID: 23329398 DOI: 10.1007/s40259-012-0005-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
296 Norata GD, Tibolla G, Catapano AL. Gene silencing approaches for the management of dyslipidaemia. Trends in Pharmacological Sciences 2013;34:198-205. [DOI: 10.1016/j.tips.2013.01.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
297 Kim J, Won R, Ban G, Ju MH, Cho KS, Young Han S, Jeong JS, Lee SW. Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation. Sci Rep. 2015;5:12315. [PMID: 26189916 DOI: 10.1038/srep12315] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
298 Kulkarni SR, Armstrong LE, Slitt AL. Caloric restriction-mediated induction of lipid metabolism gene expression in liver is enhanced by Keap1-knockdown. Pharm Res 2013;30:2221-31. [PMID: 23884569 DOI: 10.1007/s11095-013-1138-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
299 Kojima S, Gatfield D, Esau CC, Green CB. MicroRNA-122 modulates the rhythmic expression profile of the circadian deadenylase Nocturnin in mouse liver. PLoS One 2010;5:e11264. [PMID: 20582318 DOI: 10.1371/journal.pone.0011264] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
300 Costanzi E, Simioni C, Varano G, Brenna C, Conti I, Neri LM. The Role of Extracellular Vesicles as Shuttles of RNA and Their Clinical Significance as Biomarkers in Hepatocellular Carcinoma. Genes (Basel) 2021;12:902. [PMID: 34207985 DOI: 10.3390/genes12060902] [Reference Citation Analysis]
301 Shang JW, Yan XL, Zhang H, Su SB. Expression and significance of urinary microRNA in patients with chronic hepatitis B. Medicine (Baltimore). 2019;98:e17143. [PMID: 31517857 DOI: 10.1097/md.0000000000017143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
302 Zhu T, Corraze G, Plagnes-Juan E, Skiba-Cassy S. Cholesterol metabolism regulation mediated by SREBP-2, LXRα and miR-33a in rainbow trout (Oncorhynchus mykiss) both in vivo and in vitro. PLoS One 2020;15:e0223813. [PMID: 32109243 DOI: 10.1371/journal.pone.0223813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
303 Czaja AJ. Epigenetic changes and their implications in autoimmune hepatitis. Eur J Clin Invest. 2018;48. [PMID: 29383703 DOI: 10.1111/eci.12899] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
304 Stenvang J, Lindow M, Kauppinen S. Targeting of microRNAs for therapeutics. Biochem Soc Trans 2008;36:1197-200. [PMID: 19021524 DOI: 10.1042/BST0361197] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
305 Pomatto MAC, Gai C, Deregibus MC, Tetta C, Camussi G. Noncoding RNAs Carried by Extracellular Vesicles in Endocrine Diseases. Int J Endocrinol 2018;2018:4302096. [PMID: 29808089 DOI: 10.1155/2018/4302096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
306 Singh SK. miRNAs: from neurogeneration to neurodegeneration. Pharmacogenomics 2007;8:971-8. [PMID: 17716230 DOI: 10.2217/14622416.8.8.971] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
307 Mohite A, Chillar A, So S, Cervantes V, Ruan K. Novel Mechanism of the Vascular Protector Prostacyclin: Regulating MicroRNA Expression. Biochemistry 2011;50:1691-9. [DOI: 10.1021/bi101654w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
308 Sagan SM, Chahal J, Sarnow P. cis-Acting RNA elements in the hepatitis C virus RNA genome. Virus Res 2015;206:90-8. [PMID: 25576644 DOI: 10.1016/j.virusres.2014.12.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
309 Iravani F, Hosseini N, Mojarrad M. Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Middle East J Dig Dis 2018;10:213-9. [PMID: 31049168 DOI: 10.15171/mejdd.2018.113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
310 Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014;13:622-638. [PMID: 25011539 DOI: 10.1038/nrd4359] [Cited by in Crossref: 618] [Cited by in F6Publishing: 601] [Article Influence: 77.3] [Reference Citation Analysis]
311 Duygu B, Juni R, Ottaviani L, Bitsch N, Wit JBM, de Windt LJ, da Costa Martins PA. Comparison of different chemically modified inhibitors of miR-199b in vivo. Biochem Pharmacol 2019;159:106-15. [PMID: 30452907 DOI: 10.1016/j.bcp.2018.11.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
312 Lima JF, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF. Anti-miRNA oligonucleotides: A comprehensive guide for design. RNA Biol 2018;15:338-52. [PMID: 29570036 DOI: 10.1080/15476286.2018.1445959] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 13.8] [Reference Citation Analysis]
313 Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, Kellum JM, Min H, Luketic VA, Sanyal AJ. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology. 2008;48:1810-1820. [PMID: 19030170 DOI: 10.1002/hep.22569;] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
314 Ferrari A, Longo R, Silva R, Mitro N, Caruso D, De Fabiani E, Crestani M. Epigenome modifiers and metabolic rewiring: New frontiers in therapeutics. Pharmacology & Therapeutics 2019;193:178-93. [DOI: 10.1016/j.pharmthera.2018.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
315 Gramantieri L, Giovannini C, Piscaglia F, Fornari F. MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:369-85. [PMID: 34012928 DOI: 10.2147/JHC.S268292] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
316 Clarke JD, Sharapova T, Lake AD, Blomme E, Maher J, Cherrington NJ. Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis. J Appl Toxicol. 2014;34:726-732. [PMID: 24217942 DOI: 10.1002/jat.2960] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
317 Kukreti H, Amuthavalli K. MicroRNA-34a causes ceramide accumulation and effects insulin signaling pathway by targeting ceramide kinase (CERK) in aging skeletal muscle. J Cell Biochem 2020;121:3070-89. [PMID: 32056304 DOI: 10.1002/jcb.29312] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
318 Bladé C, Baselga-Escudero L, Salvadó MJ, Arola-Arnal A. miRNAs, polyphenols, and chronic disease. Mol Nutr Food Res 2013;57:58-70. [PMID: 23165995 DOI: 10.1002/mnfr.201200454] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
319 Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, Bugianesi E, Sirlin CB, Neuschwander-tetri BA, Rinella ME. Nonalcoholic fatty liver disease. Nat Rev Dis Primers 2015;1. [DOI: 10.1038/nrdp.2015.80] [Cited by in Crossref: 302] [Cited by in F6Publishing: 288] [Article Influence: 43.1] [Reference Citation Analysis]
320 Salem M, Xiao C, Womack J, Rexroad CE 3rd, Yao J. A microRNA repertoire for functional genome research in rainbow trout (Oncorhynchus mykiss). Mar Biotechnol (NY) 2010;12:410-29. [PMID: 19816740 DOI: 10.1007/s10126-009-9232-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
321 Fort A, Borel C, Migliavacca E, Antonarakis SE, Fish RJ, Neerman-Arbez M. Regulation of fibrinogen production by microRNAs. Blood. 2010;116:2608-2615. [PMID: 20570858 DOI: 10.1182/blood-2010-02-268011] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 6.1] [Reference Citation Analysis]
322 Akiyoshi K, Boersma GJ, Johnson MD, Velasquez FC, Dunkerly-Eyring B, O'Brien S, Yamaguchi A, Steenbergen C, Tamashiro KLK, Das S. Role of miR-181c in Diet-induced obesity through regulation of lipid synthesis in liver. PLoS One 2021;16:e0256973. [PMID: 34879063 DOI: 10.1371/journal.pone.0256973] [Reference Citation Analysis]
323 Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease. PLoS One. 2011;6:e23937. [PMID: 21886843 DOI: 10.1371/journal.pone.0023937;] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
324 Dang Y, Xu J, Zhu M, Zhou W, Zhang L, Ji G. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.Biomed Pharmacother. 2020;127:110127. [PMID: 32325349 DOI: 10.1016/j.biopha.2020.110127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
325 Zambrano T, Hirata RDC, Hirata MH, Cerda Á, Salazar LA. Altered microRNome Profiling in Statin-Induced HepG2 Cells: A Pilot Study Identifying Potential new Biomarkers Involved in Lipid-Lowering Treatment. Cardiovasc Drugs Ther 2015;29:509-18. [PMID: 26602562 DOI: 10.1007/s10557-015-6627-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
326 Blackham S, Baillie A, Al-Hababi F, Remlinger K, You S, Hamatake R, McGarvey MJ. Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus. J Virol. 2010;84:5404-5414. [PMID: 20200238 DOI: 10.1128/jvi.02529-09] [Cited by in Crossref: 92] [Cited by in F6Publishing: 70] [Article Influence: 7.7] [Reference Citation Analysis]
327 Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol 2014;51:759-74. [PMID: 24045890 DOI: 10.1177/0300985813502820] [Cited by in Crossref: 194] [Cited by in F6Publishing: 200] [Article Influence: 21.6] [Reference Citation Analysis]
328 Li P. MicroRNAs in Cardiac Apoptosis. J of Cardiovasc Trans Res 2010;3:219-24. [DOI: 10.1007/s12265-010-9175-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
329 Thatcher EJ, Patton JG. Small RNAs have a big impact on regeneration. RNA Biol 2010;7:333-8. [PMID: 20458186 DOI: 10.4161/rna.7.3.12085] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
330 Moscoso CG, Steer CJ. The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases. Genes (Basel) 2020;11:E915. [PMID: 32785089 DOI: 10.3390/genes11080915] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
331 Brandao BB, Lino M, Kahn CR. Extracellular miRNAs as mediators of obesity-associated disease. J Physiol 2021. [PMID: 34392542 DOI: 10.1113/JP280910] [Reference Citation Analysis]
332 Garbacki N, Di Valentin E, Huynh-Thu VA, Geurts P, Irrthum A, Crahay C, Arnould T, Deroanne C, Piette J, Cataldo D. MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS One. 2011;6:e16509. [PMID: 21305051 DOI: 10.1371/journal.pone.0016509.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
333 Luna JM, Michailidis E, Rice CM. Mopping up miRNA: An integrated HBV transcript disrupts liver homeostasis by sequestering miR-122. J Hepatol. 2016;64:257-259. [PMID: 26541590 DOI: 10.1016/j.jhep.2015.10.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
334 Rome S. Are extracellular microRNAs involved in type 2 diabetes and related pathologies? Clin Biochem. 2013;46:937-945. [PMID: 23499584 DOI: 10.1016/j.clinbiochem.2013.02.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
335 Chen Y, Verfaillie CM. MicroRNAs: the fine modulators of liver development and function. Liver Int. 2014;34:976-990. [PMID: 24517588 DOI: 10.1111/liv.12496] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
336 Zhang G, Wang Q, Xu R. Therapeutics Based on microRNA: A New Approach for Liver Cancer. Curr Genomics 2010;11:311-25. [PMID: 21286309 DOI: 10.2174/138920210791616671] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
337 Hong X, Qin J, Chen R, Yuan L, Zha J, Wang Z. Identification and characterization of novel and conserved microRNAs in several tissues of the Chinese rare minnow (Gobiocypris rarus) based on illumina deep sequencing technology. BMC Genomics 2016;17:283. [PMID: 27066897 DOI: 10.1186/s12864-016-2606-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
338 Liu XL, Cao HX, Fan JG. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease. J Dig Dis. 2016;17:708-715. [PMID: 27628945 DOI: 10.1111/1751-2980.12408] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
339 Liu W, Cao H, Yan J, Huang R, Ying H. 'Micro-managers' of hepatic lipid metabolism and NAFLD. Wiley Interdiscip Rev RNA. 2015;6:581-593. [PMID: 26198708 DOI: 10.1002/wrna.1295] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
340 Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 2008;180:5689-98. [PMID: 18390754 DOI: 10.4049/jimmunol.180.8.5689] [Cited by in Crossref: 306] [Cited by in F6Publishing: 307] [Article Influence: 21.9] [Reference Citation Analysis]
341 Gong W, Huang Y, Xie J, Wang G, Yu D, Sun X. Genome-wide identification and characterization of conserved and novel microRNAs in grass carp ( Ctenopharyngodon idella ) by deep sequencing. Computational Biology and Chemistry 2017;68:92-100. [DOI: 10.1016/j.compbiolchem.2017.02.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
342 Vincent R, Sanyal A. Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. Curr Pathobiol Rep 2014;2:109-15. [PMID: 25574453 DOI: 10.1007/s40139-014-0049-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
343 Sidorkiewicz M, Grek M, Jozwiak B, Krol A, Piekarska A. The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expression. Eur J Clin Microbiol Infect Dis 2017;36:697-702. [PMID: 27888401 DOI: 10.1007/s10096-016-2851-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
344 Sun L, He X, Cao Y, Gao P, Zhang H. MicroRNAs and Energy Metabolism in Cancer Cells. In: Babashah S, editor. MicroRNAs: Key Regulators of Oncogenesis. Cham: Springer International Publishing; 2014. pp. 83-95. [DOI: 10.1007/978-3-319-03725-7_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
345 Delik A, Dinçer S, Akkız H. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesis. Meta Gene 2020;24:100647. [DOI: 10.1016/j.mgene.2020.100647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
346 Sun K, Lai EC. Adult-specific functions of animal microRNAs. Nat Rev Genet. 2013;14:535-548. [PMID: 23817310 DOI: 10.1038/nrg3471] [Cited by in Crossref: 230] [Cited by in F6Publishing: 214] [Article Influence: 25.6] [Reference Citation Analysis]
347 Chen Y, Zhou Y, Han F, Zhao Y, Tu M, Wang Y, Huang C, Fan S, Chen P, Yao X, Guan L, Yu AM, Gonzalez FJ, Huang M, Bi H. A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis. Theranostics 2020;10:7193-210. [PMID: 32641987 DOI: 10.7150/thno.44877] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
348 Zhou L, Hussain MM. Human MicroRNA-548p Decreases Hepatic Apolipoprotein B Secretion and Lipid Synthesis. Arterioscler Thromb Vasc Biol 2017;37:786-93. [PMID: 28336556 DOI: 10.1161/ATVBAHA.117.309247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
349 Quiat D, Olson EN. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest 2013;123:11-8. [PMID: 23281405 DOI: 10.1172/JCI62876] [Cited by in Crossref: 173] [Cited by in F6Publishing: 110] [Article Influence: 19.2] [Reference Citation Analysis]
350 Bozaykut P, Sahin A, Karademir B, Ozer NK. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis. Mechanisms of Ageing and Development 2016;157:17-29. [DOI: 10.1016/j.mad.2016.07.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
351 Zhou X, Cui L, Zhou X, Yang Q, Wang L, Guo G, Hou Y, Cai W, Han Z, Shi Y, Han Y. Induction of hepatocyte-like cells from human umbilical cord-derived mesenchymal stem cells by defined microRNAs. J Cell Mol Med. 2017;21:881-893. [PMID: 27874233 DOI: 10.1111/jcmm.13027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
352 Heneghan HM, Miller N, Kerin MJ. Role of microRNAs in obesity and the metabolic syndrome. Obes Rev. 2010;11:354-361. [PMID: 19793375 DOI: 10.1111/j.1467-789x.2009.00659.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 70] [Article Influence: 10.8] [Reference Citation Analysis]
353 Vickers KC, Rye KA, Tabet F. MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond). 2014;126:183-194. [PMID: 24102098 DOI: 10.1042/cs20130203] [Cited by in Crossref: 70] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
354 Jung HS, Seo Y, Yang YM, Koo JH, An J, Lee SJ, Kim KM, Kim SG. Gα12 gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation. Cellular Signalling 2014;26:1456-65. [DOI: 10.1016/j.cellsig.2014.02.022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
355 Rogobete AF, Sandesc D, Papurica M, Stoicescu ER, Popovici SE, Bratu LM, Vernic C, Sas AM, Stan AT, Bedreag OH. The influence of metabolic imbalances and oxidative stress on the outcome of critically ill polytrauma patients: a review. Burns Trauma 2017;5:8. [PMID: 28286784 DOI: 10.1186/s41038-017-0073-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
356 Mack GS. MicroRNA gets down to business. Nat Biotechnol 2007;25:631-8. [PMID: 17557095 DOI: 10.1038/nbt0607-631] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 5.8] [Reference Citation Analysis]
357 Bhat AA, Younes SN, Raza SS, Zarif L, Nisar S, Ahmed I, Mir R, Kumar S, Sharawat SK, Hashem S, Elfaki I, Kulinski M, Kuttikrishnan S, Prabhu KS, Khan AQ, Yadav SK, El-Rifai W, Zargar MA, Zayed H, Haris M, Uddin S. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Mol Cancer 2020;19:57. [PMID: 32164715 DOI: 10.1186/s12943-020-01175-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
358 Bayoumi A, Grønbæk H, George J, Eslam M. The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease. Trends Genet 2020;36:429-41. [PMID: 32396836 DOI: 10.1016/j.tig.2020.03.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
359 Yoshikawa T, Takata A, Otsuka M, Kishikawa T, Kojima K, Yoshida H, Koike K. Silencing of microRNA-122 enhances interferon-α signaling in the liver through regulating SOCS3 promoter methylation. Sci Rep. 2012;2:637. [PMID: 22957141 DOI: 10.1038/srep00637] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
360 Schug J, McKenna LB, Walton G, Hand N, Mukherjee S, Essuman K, Shi Z, Gao Y, Markley K, Nakagawa M, Kameswaran V, Vourekas A, Friedman JR, Kaestner KH, Greenbaum LE. Dynamic recruitment of microRNAs to their mRNA targets in the regenerating liver. BMC Genomics 2013;14:264. [PMID: 23597149 DOI: 10.1186/1471-2164-14-264] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
361 Sheridan DA, Price DA, Schmid ML, Toms GL, Donaldson P, Neely D, Bassendine MF. Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin. Alimentary Pharmacology & Therapeutics 2009;29:1282-90. [DOI: 10.1111/j.1365-2036.2009.04012.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
362 Bae YU, Kim Y, Lee H, Kim H, Jeon JS, Noh H, Han DC, Ryu S, Kwon SH. Bariatric Surgery Alters microRNA Content of Circulating Exosomes in Patients with Obesity. Obesity (Silver Spring) 2019;27:264-71. [PMID: 30624857 DOI: 10.1002/oby.22379] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
363 Davis S, Lollo B, Freier S, Esau C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 2006;34:2294-2304. [PMID: 16690972 DOI: 10.1093/nar/gkl183] [Cited by in Crossref: 282] [Cited by in F6Publishing: 268] [Article Influence: 17.6] [Reference Citation Analysis]
364 Chai C, Rivkin M, Berkovits L, Simerzin A, Zorde-Khvalevsky E, Rosenberg N, Klein S, Yaish D, Durst R, Shpitzen S, Udi S, Tam J, Heeren J, Worthmann A, Schramm C, Kluwe J, Ravid R, Hornstein E, Giladi H, Galun E. Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues. Gastroenterology 2017;153:1404-15. [PMID: 28802563 DOI: 10.1053/j.gastro.2017.08.013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
365 Kohler M, Schänzer W, Thevis M. RNA interference for performance enhancement and detection in doping control. Drug Test Anal 2011;3:661-7. [PMID: 22031503 DOI: 10.1002/dta.330] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
366 Boix L, López-Oliva JM, Rhodes AC, Bruix J. Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-β pathway. Oncotarget 2016;7:71309-29. [PMID: 27612430 DOI: 10.18632/oncotarget.11885] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
367 Langlet F, Tarbier M, Haeusler RA, Camastra S, Ferrannini E, Friedländer MR, Accili D. microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function. Mol Metab 2018;17:49-60. [PMID: 30174230 DOI: 10.1016/j.molmet.2018.08.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
368 Lewis AP, Jopling CL. Regulation and biological function of the liver-specific miR-122. Biochem Soc Trans. 2010;38:1553-1557. [PMID: 21118125 DOI: 10.1042/bst0381553] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
369 Cohen A, Smith Y. Estrogen regulation of microRNAs, target genes, and microRNA expression associated with vitellogenesis in the zebrafish. Zebrafish 2014;11:462-78. [PMID: 23767875 DOI: 10.1089/zeb.2013.0873] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
370 Gusic M, Prokisch H. ncRNAs: New Players in Mitochondrial Health and Disease? Front Genet 2020;11:95. [PMID: 32180794 DOI: 10.3389/fgene.2020.00095] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
371 Xie J, Burt DR, Gao G. Adeno-associated virus-mediated microRNA delivery and therapeutics. Semin Liver Dis. 2015;35:81-88. [PMID: 25632938 DOI: 10.1055/s-0034-1397352] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
372 Zeng C, Sang Y, Wang FY, Zhuang SM. Opposing roles of C/EBPα and eEF1A1 in Sp1-regulated miR-122 transcription. RNA Biol 2020;17:202-10. [PMID: 31561740 DOI: 10.1080/15476286.2019.1673656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
373 Kerr TA, Korenblat KM, Davidson NO. MicroRNAs and liver disease. Transl Res. 2011;157:241-252. [PMID: 21420035 DOI: 10.1016/j.trsl.2011.01.008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
374 Bhattarai A, Likos EM, Weyman CM, Shukla GC. Regulation of cholesterol biosynthesis and lipid metabolism: A microRNA management perspective. Steroids 2021;173:108878. [PMID: 34174291 DOI: 10.1016/j.steroids.2021.108878] [Reference Citation Analysis]
375 Mäkinen PI, Ylä-Herttuala S. Therapeutic gene targeting approaches for the treatment of dyslipidemias and atherosclerosis. Curr Opin Lipidol 2013;24:116-22. [PMID: 23314926 DOI: 10.1097/MOL.0b013e32835da13c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
376 Wei S, Zhang M, Yu Y, Xue H, Lan X, Liu S, Hatch G, Chen L. HNF-4α regulated miR-122 contributes to development of gluconeogenesis and lipid metabolism disorders in Type 2 diabetic mice and in palmitate-treated HepG2 cells. Eur J Pharmacol 2016;791:254-63. [PMID: 27592052 DOI: 10.1016/j.ejphar.2016.08.038] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
377 Mirzadeh Azad F, Arabian M, Maleki M, Malakootian M. Small Molecules with Big Impacts on Cardiovascular Diseases. Biochem Genet 2020;58:359-83. [PMID: 31997044 DOI: 10.1007/s10528-020-09948-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
378 Roberts AP, Jopling CL. Targeting viral infection by microRNA inhibition. Genome Biol. 2010;11:201. [PMID: 20122293 DOI: 10.1186/gb-2010-11-1-201] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
379 Zhou M, Hara H, Dai Y, Mou L, Cooper DK, Wu C, Cai Z. Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation. Int J Mol Sci 2016;17:E1232. [PMID: 27490531 DOI: 10.3390/ijms17081232] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
380 Ottosen S, Parsley TB, Yang L, Zeh K, van Doorn LJ, van der Veer E, Raney AK, Hodges MR, Patick AK. In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. Antimicrob Agents Chemother. 2015;59:599-608. [PMID: 25385103 DOI: 10.1128/aac.04220-14] [Cited by in Crossref: 116] [Cited by in F6Publishing: 70] [Article Influence: 14.5] [Reference Citation Analysis]
381 Yu F, Jiang Z, Chen B, Dong P, Zheng J. NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6. J Mol Med (Berl) 2017;95:1191-202. [PMID: 28864835 DOI: 10.1007/s00109-017-1586-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
382 Pollutri D, Gramantieri L, Bolondi L, Fornari F. TP53/MicroRNA Interplay in Hepatocellular Carcinoma. Int J Mol Sci. 2016;17. [PMID: 27918441 DOI: 10.3390/ijms17122029] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
383 Atri C, Guerfali FZ, Laouini D. MicroRNAs in diagnosis and therapeutics. AGO-Driven Non-Coding RNAs. Elsevier; 2019. pp. 137-77. [DOI: 10.1016/b978-0-12-815669-8.00006-3] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
384 Sugiyama K, Ebinuma H, Nakamoto N, Sakasegawa N, Murakami Y, Chu PS, Usui S, Ishibashi Y, Wakayama Y, Taniki N. Prominent steatosis with hypermetabolism of the cell line permissive for years of infection with hepatitis C virus. PLoS One. 2014;9:e94460. [PMID: 24718268 DOI: 10.1371/journal.pone.0094460] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
385 Zhao E, Keller MP, Rabaglia ME, Oler AT, Stapleton DS, Schueler KL, Neto EC, Moon JY, Wang P, Wang IM, Lum PY, Ivanovska I, Cleary M, Greenawalt D, Tsang J, Choi YJ, Kleinhanz R, Shang J, Zhou YP, Howard AD, Zhang BB, Kendziorski C, Thornberry NA, Yandell BS, Schadt EE, Attie AD. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm Genome 2009;20:476-85. [PMID: 19727952 DOI: 10.1007/s00335-009-9217-2] [Cited by in Crossref: 98] [Cited by in F6Publishing: 102] [Article Influence: 8.2] [Reference Citation Analysis]
386 Lasunción MA, Martín-sánchez C, Canfrán-duque A, Busto R. Post-lanosterol biosynthesis of cholesterol and cancer. Current Opinion in Pharmacology 2012;12:717-23. [DOI: 10.1016/j.coph.2012.07.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
387 Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101:2999-3004. [PMID: 14973191 DOI: 10.1073/pnas.0307323101] [Cited by in Crossref: 2725] [Cited by in F6Publishing: 2605] [Article Influence: 151.4] [Reference Citation Analysis]
388 Heo MJ, Yun J, Kim SG. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma. Arch Pharm Res 2019;42:48-62. [PMID: 30610616 DOI: 10.1007/s12272-018-01104-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
389 Monchusi B, Kaur M. microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance. Genes Cancer 2020;11:20-42. [PMID: 32577155 DOI: 10.18632/genesandcancer.202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
390 Gimadiev PP, Niiazov AR, Mukhin VE, Ogurtsov PP. [The Diagnostic Importance of Circulating MicroRNA for Non-Alcoholic Fatty Liver Disease (review of literature).]. Klin Lab Diagn 2019;64:723-9. [PMID: 32040895 DOI: 10.18821/0869-2084-2019-64-12-723-729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
391 Torres AG, Fabani MM, Vigorito E, Gait MJ. MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection. RNA. 2011;17:933-943. [PMID: 21441346 DOI: 10.1261/rna.2533811] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 5.8] [Reference Citation Analysis]
392 Hsu SH, Ghoshal K. MicroRNAs in Liver Health and Disease. Curr Pathobiol Rep 2013;1:53-62. [PMID: 23565350 DOI: 10.1007/s40139-012-0005-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
393 Sahebkar A, Chew GT, Watts GF. Recent advances in pharmacotherapy for hypertriglyceridemia. Prog Lipid Res 2014;56:47-66. [PMID: 25083925 DOI: 10.1016/j.plipres.2014.07.002] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 11.6] [Reference Citation Analysis]
394 Mortimer SA, Doudna JA. Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure. Nucleic Acids Res. 2013;41:4230-4240. [PMID: 23416544 DOI: 10.1093/nar/gkt075] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 7.4] [Reference Citation Analysis]
395 Zhang X, Price NL, Fernández-Hernando C. Non-coding RNAs in lipid metabolism. Vascul Pharmacol 2019;114:93-102. [PMID: 29929012 DOI: 10.1016/j.vph.2018.06.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
396 Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E. Breast cancer and microRNAs: therapeutic impact. Breast 2011;20 Suppl 3:S63-70. [PMID: 22015296 DOI: 10.1016/S0960-9776(11)70297-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
397 Sen CK, Gordillo GM, Khanna S, Roy S. Micromanaging vascular biology: tiny microRNAs play big band. J Vasc Res 2009;46:527-40. [PMID: 19571573 DOI: 10.1159/000226221] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 5.5] [Reference Citation Analysis]
398 Joven J, Espinel E, Rull A, Aragonès G, Rodríguez-Gallego E, Camps J, Micol V, Herranz-López M, Menéndez JA, Borrás I. Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochim Biophys Acta. 2012;1820:894-899. [PMID: 22503922 DOI: 10.1016/j.bbagen.2012.03.020] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 8.9] [Reference Citation Analysis]
399 Xiao L, Rao JN, Zou T, Liu L, Cao S, Martindale JL, Su W, Chung HK, Gorospe M, Wang JY. miR-29b represses intestinal mucosal growth by inhibiting translation of cyclin-dependent kinase 2. Mol Biol Cell 2013;24:3038-46. [PMID: 23904268 DOI: 10.1091/mbc.E13-05-0287] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
400 Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One. 2011;6:e28486. [PMID: 22174818 DOI: 10.1371/journal.pone.0028486] [Cited by in Crossref: 199] [Cited by in F6Publishing: 200] [Article Influence: 18.1] [Reference Citation Analysis]
401 Ariyoshi J, Matsuyama Y, Kobori A, Murakami A, Sugiyama H, Yamayoshi A. Effective Anti-miRNA Oligonucleotides Show High Releasing Rate of MicroRNA from RNA-Induced Silencing Complex. Nucleic Acid Ther 2017;27:303-8. [PMID: 28876213 DOI: 10.1089/nat.2017.0663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
402 Jafri MA, Zaidi SK, Ansari SA, Al-Qahtani MH, Shay JW. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer. Expert Opin Ther Targets 2015;19:1705-23. [PMID: 26189482 DOI: 10.1517/14728222.2015.1069816] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
403 Etchegaray E, Naville M, Volff JN, Haftek-Terreau Z. Transposable element-derived sequences in vertebrate development. Mob DNA 2021;12:1. [PMID: 33407840 DOI: 10.1186/s13100-020-00229-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
404 Fan Y, Ma X, Li H, Gao Y, Huang Q, Zhang Y, Bao X, Du Q, Luo G, Liu K, Meng Q, Zhao C, Zhang X. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer. Int J Cancer 2018;142:547-60. [PMID: 28921581 DOI: 10.1002/ijc.31050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
405 Shibata C, Kishikawa T, Otsuka M, Ohno M, Yoshikawa T, Takata A, Yoshida H, Koike K. Inhibition of microRNA122 decreases SREBP1 expression by modulating suppressor of cytokine signaling 3 expression. Biochem Biophys Res Commun. 2013;438:230-235. [PMID: 23891753 DOI: 10.1016/j.bbrc.2013.07.064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
406 Tomasetti M, Lee W, Santarelli L, Neuzil J. Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy. Exp Mol Med 2017;49:e285. [PMID: 28104913 DOI: 10.1038/emm.2016.153] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 20.0] [Reference Citation Analysis]
407 Witting SR, Brown M, Saxena R, Nabinger S, Morral N. Helper-dependent Adenovirus-mediated Short Hairpin RNA Expression in the Liver Activates the Interferon Response. Journal of Biological Chemistry 2008;283:2120-8. [DOI: 10.1074/jbc.m704178200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
408 Suksangrat T, Phannasil P, Jitrapakdee S. miRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-alcoholic Fatty Liver Disease. In: Guest PC, editor. Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders. Cham: Springer International Publishing; 2019. pp. 129-48. [DOI: 10.1007/978-3-030-12668-1_7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
409 Peixoto TC, Gaspar de Moura E, Quitete FT, Simino LA, Torsoni AS, Torsoni MA, Manhaes AC, Lisboa PC. Early life nicotine exposure alters mRNA and microRNA expressions related to thyroid function and lipid metabolism in liver and BAT of adult wistar rats. Mol Cell Endocrinol 2021;523:111141. [PMID: 33359828 DOI: 10.1016/j.mce.2020.111141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
410 Valdmanis PN, Gu S, Chu K, Jin L, Zhang F, Munding EM, Zhang Y, Huang Y, Kutay H, Ghoshal K, Lisowski L, Kay MA. RNA interference-induced hepatotoxicity results from loss of the first synthesized isoform of microRNA-122 in mice. Nat Med 2016;22:557-62. [PMID: 27064447 DOI: 10.1038/nm.4079] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
411 Zampetaki A, Dudek K, Mayr M. Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling. Free Radic Biol Med 2013;64:69-77. [PMID: 23797034 DOI: 10.1016/j.freeradbiomed.2013.06.025] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
412 Latronico MV, Condorelli G. Therapeutic use of microRNAs in myocardial diseases. Curr Heart Fail Rep 2011;8:193-7. [PMID: 21713604 DOI: 10.1007/s11897-011-0068-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
413 Yu C, Chen W, Wang X. MicroRNA in Osteoarthritis. J Int Med Res 2011;39:1-9. [DOI: 10.1177/147323001103900101] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
414 Brandt S, Roos J, Inzaghi E, Kotnik P, Kovac J, Battelino T, Cianfarani S, Nobili V, Colajacomo M, Kratzer W, Denzer C, Fischer-posovszky P, Wabitsch M. Circulating levels of miR-122 and nonalcoholic fatty liver disease in pre-pubertal obese children: Circulating miR-122 in obesity and NAFLD. Pediatric Obesity 2018;13:175-82. [DOI: 10.1111/ijpo.12261] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
415 Lin J, Maimaitiyiming A, Chen S, Xiao M, Xian Z. Hypoxia-induced miR-27 and miR-195 regulate ATP consumption, viability, and metabolism of rat cardiomyocytes by targeting PPARγ and FASN expression. Aging (Albany NY) 2021;13:10158-74. [PMID: 33819184 DOI: 10.18632/aging.202778] [Reference Citation Analysis]
416 Rottiers V, Näär AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13:239-250. [PMID: 22436747 DOI: 10.1038/nrm3328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
417 Zhou XJ, Wang J, Ye HH, Fa YZ. Signature MicroRNA expression profile is associated with lipid metabolism in African green monkey. Lipids Health Dis 2019;18:55. [PMID: 30819205 DOI: 10.1186/s12944-019-0999-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
418 Karere GM, Glenn JP, VandeBerg JL, Cox LA. Differential microRNA response to a high-cholesterol, high-fat diet in livers of low and high LDL-C baboons. BMC Genomics 2012;13:320. [PMID: 22809019 DOI: 10.1186/1471-2164-13-320] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
419 Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008;3:e3740. [PMID: 19011694 DOI: 10.1371/journal.pone.0003740] [Cited by in Crossref: 358] [Cited by in F6Publishing: 341] [Article Influence: 25.6] [Reference Citation Analysis]
420 Willebrords J, Pereira IV, Maes M, Crespo Yanguas S, Colle I, Van Den Bossche B, Da Silva TC, de Oliveira CP, Andraus W, Alves VA. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Prog Lipid Res. 2015;59:106-125. [PMID: 26073454 DOI: 10.1016/j.plipres.2015.05.002] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 12.1] [Reference Citation Analysis]
421 Tang Y, Liu M, Xu L, Tian J, Yang X, Zhao Y, Zhao S. A simple and rapid dual-cycle amplification strategy for microRNA based on graphene oxide and exonuclease III-assisted fluorescence recovery. Anal Methods 2018;10:3777-82. [DOI: 10.1039/c8ay01106k] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
422 Wang T, Li M, Guan J, Li P, Wang H, Guo Y, Shuai S, Li X. MicroRNAs miR-27a and miR-143 regulate porcine adipocyte lipid metabolism. Int J Mol Sci 2011;12:7950-9. [PMID: 22174642 DOI: 10.3390/ijms12117950] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
423 De Clercq E. The race for interferon-free HCV therapies: a snapshot by the spring of 2012: Interferon-free HCV therapies. Rev Med Virol 2012;22:392-411. [DOI: 10.1002/rmv.1727] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
424 Iorio MV, Croce CM. Causes and consequences of microRNA dysregulation. Cancer J. 2012;18:215-222. [PMID: 22647357 DOI: 10.1097/ppo.0b013e318250c001] [Cited by in Crossref: 186] [Cited by in F6Publishing: 112] [Article Influence: 18.6] [Reference Citation Analysis]
425 Zhang D, Wang Y, Ji Z, Wang Z. Identification and differential expression of microRNAs associated with fat deposition in the liver of Wistar rats with nonalcoholic fatty liver disease. Gene 2016;585:1-8. [PMID: 26971813 DOI: 10.1016/j.gene.2016.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
426 Piccinin E, Arconzo M, Graziano G, Vacca M, Peres C, Bellafante E, Villani G, Moschetta A. Hepatic microRNA Expression by PGC-1α and PGC-1β in the Mouse. Int J Mol Sci 2019;20:E5735. [PMID: 31731670 DOI: 10.3390/ijms20225735] [Reference Citation Analysis]
427 Franco S, Buccione D, Tural C, Martinez MA. Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/hepatitis C virus coinfections. AIDS 2021;35:1355-63. [PMID: 33813557 DOI: 10.1097/QAD.0000000000002895] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2008;375:315-320. [PMID: 18692484 DOI: 10.1016/j.bbrc.2008.07.154] [Cited by in Crossref: 180] [Cited by in F6Publishing: 180] [Article Influence: 12.9] [Reference Citation Analysis]
429 O'Reilly S. MicroRNAs in fibrosis: opportunities and challenges. Arthritis Res Ther. 2016;18:11. [PMID: 26762516 DOI: 10.1186/s13075-016-0929-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 15.2] [Reference Citation Analysis]
430 Zhou Y, Wang Y, Su J, Wu Z, Wang C, Zhong W, Liu X, Cui L, Zhou X, Ma Y, Xin Y, Zhang J, Wu L, Hu X, Chen X, Peng C, Gao M. Integration of microRNAome, proteomics and metabolomics to analyze arsenic-induced malignant cell transformation. Oncotarget 2017;8:90879-96. [PMID: 29207610 DOI: 10.18632/oncotarget.18741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
431 Economou EK, Oikonomou E, Siasos G, Papageorgiou N, Tsalamandris S, Mourouzis K, Papaioanou S, Tousoulis D. The role of microRNAs in coronary artery disease: From pathophysiology to diagnosis and treatment. Atherosclerosis 2015;241:624-33. [DOI: 10.1016/j.atherosclerosis.2015.06.037] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 8.6] [Reference Citation Analysis]
432 Guo YE, Steitz JA. Virus meets host microRNA: the destroyer, the booster, the hijacker. Mol Cell Biol. 2014;34:3780-3787. [PMID: 25047834 DOI: 10.1128/mcb.00871-14] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 8.4] [Reference Citation Analysis]
433 Pillai SS, Lakhani HV, Zehra M, Wang J, Dilip A, Puri N, O'Hanlon K, Sodhi K. Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population. Int J Mol Sci 2020;21:E6698. [PMID: 32933141 DOI: 10.3390/ijms21186698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
434 Denby L, Baker AH. Targeting non-coding RNA for the therapy of renal disease. Curr Opin Pharmacol 2016;27:70-7. [PMID: 26921871 DOI: 10.1016/j.coph.2016.02.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
435 Tan Y, Ge G, Pan T, Wen D, Gan J. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS One. 2014;9:e105192. [PMID: 25141008 DOI: 10.1371/journal.pone.0105192] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 11.5] [Reference Citation Analysis]
436 Robertson KA, Ghazal P. Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection. Front Immunol 2016;7:634. [PMID: 28066443 DOI: 10.3389/fimmu.2016.00634] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
437 Chapuis H, Bui L, Bestel I, Barthélémy P. 2′-Lipid-modified oligonucleotides via a ‘Staudinger–Vilarrasa’ reaction. Tetrahedron Letters 2008;49:6838-40. [DOI: 10.1016/j.tetlet.2008.09.078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
438 Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers (Basel) 2021;13:514. [PMID: 33572780 DOI: 10.3390/cancers13030514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
439 Jiang H, Zhang J, Du Y, Jia X, Yang F, Si S, Wang L, Hong B. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator. Atherosclerosis 2015;243:523-32. [DOI: 10.1016/j.atherosclerosis.2015.10.026] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
440 Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev 2009;30:624-712. [PMID: 19776209 DOI: 10.1210/er.2009-0012] [Cited by in Crossref: 409] [Cited by in F6Publishing: 366] [Article Influence: 31.5] [Reference Citation Analysis]
441 Xu Y, Miao C, Cui J, Bian X. miR-92a-3p promotes ox-LDL induced-apoptosis in HUVECs via targeting SIRT6 and activating MAPK signaling pathway. Braz J Med Biol Res 2021;54:e9386. [PMID: 33470395 DOI: 10.1590/1414-431X20209386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
442 Marquez RT, McCaffrey AP. Advances in microRNAs: implications for gene therapists. Hum Gene Ther. 2008;19:27-38. [PMID: 18092919 DOI: 10.1089/hum.2007.147] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
443 O’Hara SP, Mott JL, Splinter PL, Gores GJ, LaRusso NF. MicroRNAs: key modulators of posttranscriptional gene expression. Gastroenterology. 2009;136:17-25. [PMID: 19049808 DOI: 10.1053/j.gastro.2008.11.028] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
444 Wan WB, Seth PP. The Medicinal Chemistry of Therapeutic Oligonucleotides. J Med Chem 2016;59:9645-67. [PMID: 27434100 DOI: 10.1021/acs.jmedchem.6b00551] [Cited by in Crossref: 146] [Cited by in F6Publishing: 122] [Article Influence: 24.3] [Reference Citation Analysis]
445 Wang Y, Chen T, Tong W. miRNAs and their application in drug-induced liver injury. Biomark Med. 2014;8:161-172. [PMID: 24521012 DOI: 10.2217/bmm.13.147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
446 Castoldi M, Muckenthaler MU. Regulation of iron homeostasis by microRNAs. Cell Mol Life Sci 2012;69:3945-52. [PMID: 22678662 DOI: 10.1007/s00018-012-1031-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
447 Ghai V, Baxter D, Wu X, Kim TK, Kuusisto J, Laakso M, Connolly T, Li Y, Andrade-Gordon P, Wang K. Circulating RNAs as predictive markers for the progression of type 2 diabetes. J Cell Mol Med 2019;23:2753-68. [PMID: 30734465 DOI: 10.1111/jcmm.14182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
448 Fullaondo A, Lee SY. Identification of putative miRNA involved in Drosophila melanogaster immune response. Developmental & Comparative Immunology 2012;36:267-73. [DOI: 10.1016/j.dci.2011.03.034] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
449 Broermann A, Schmid R, Gabrielyan O, Sakowski M, Eisele C, Keller S, Wolff M, Baum P, Stierstorfer B, Huber J, Krämer BK, Hocher B, Streicher R, Delić D. Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats. Int J Mol Sci 2020;22:E382. [PMID: 33396535 DOI: 10.3390/ijms22010382] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
450 Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: a new source of biomarkers. Mutat Res. 2011;717:85-90. [PMID: 21402084 DOI: 10.1016/j.mrfmmm.2011.03.004] [Cited by in Crossref: 421] [Cited by in F6Publishing: 378] [Article Influence: 38.3] [Reference Citation Analysis]
451 Schueller F, Roy S, Vucur M, Trautwein C, Luedde T, Roderburg C. The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity. Int J Mol Sci. 2018;19:pii: E261. [PMID: 29337905 DOI: 10.3390/ijms19010261] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 13.0] [Reference Citation Analysis]
452 Strietholt S, Maurer B, Peters MA, Pap T, Gay S. Epigenetic modifications in rheumatoid arthritis. Arthritis Res Ther 2008;10:219. [PMID: 18947370 DOI: 10.1186/ar2500] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
453 Zeng X, Li Z, Zhu C, Xu L, Sun Y, Han S. Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors. Drug Deliv 2021;28:2329-47. [PMID: 34730054 DOI: 10.1080/10717544.2021.1995081] [Reference Citation Analysis]
454 Dávalos A, Goedeke L, Smibert P, Ramírez CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U, Pastor-Pareja JC. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci USA. 2011;108:9232-9237. [PMID: 21576456 DOI: 10.1073/pnas.1102281108] [Cited by in Crossref: 453] [Cited by in F6Publishing: 429] [Article Influence: 41.2] [Reference Citation Analysis]
455 Deshpande DA, Dileepan M, Walseth TF, Subramanian S, Kannan MS. MicroRNA Regulation of Airway Inflammation and Airway Smooth Muscle Function: Relevance to Asthma. Drug Dev Res 2015;76:286-95. [PMID: 26587803 DOI: 10.1002/ddr.21267] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
456 Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122--a key factor and therapeutic target in liver disease. J Hepatol. 2015;62:448-457. [PMID: 25308172 DOI: 10.1016/j.jhep.2014.10.004] [Cited by in Crossref: 315] [Cited by in F6Publishing: 313] [Article Influence: 39.4] [Reference Citation Analysis]
457 Zhang H, Chen T, Xiong J, Hu B, Luo J, Xi Q, Jiang Q, Sun J, Zhang Y. MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction. Front Endocrinol (Lausanne) 2020;11:92. [PMID: 32194503 DOI: 10.3389/fendo.2020.00092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
458 Momtazi AA, Banach M, Pirro M, Stein EA, Sahebkar A. MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia? Clin Rev Allergy Immunol 2018;54:224-33. [PMID: 28534160 DOI: 10.1007/s12016-017-8611-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
459 Varnholt H. The role of microRNAs in primary liver cancer. Annals of Hepatology 2008;7:104-13. [DOI: 10.1016/s1665-2681(19)31864-2] [Cited by in Crossref: 40] [Article Influence: 2.9] [Reference Citation Analysis]
460 Wang L, Shao J, Zhang X, Xu M, Zhao J. microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6. Tumour Biol 2015;36:3911-7. [PMID: 25577249 DOI: 10.1007/s13277-014-3034-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
461 Yu H, Liu C, Wang J, Han J, Zhang F, Zhou X, Wen Y, Shen T. miRNA and miRNA target genes in intervention effect of Zhuyu pill on cholestatic rat model. J Ethnopharmacol 2022;283:114709. [PMID: 34626777 DOI: 10.1016/j.jep.2021.114709] [Reference Citation Analysis]
462 Hendrickson DG, Hogan DJ, Herschlag D, Ferrell JE, Brown PO. Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance. PLoS One. 2008;3:e2126. [PMID: 18461144 DOI: 10.1371/journal.pone.0002126] [Cited by in Crossref: 119] [Cited by in F6Publishing: 135] [Article Influence: 8.5] [Reference Citation Analysis]
463 Ahanda ML, Zerjal T, Dhorne-Pollet S, Rau A, Cooksey A, Giuffra E. Impact of the genetic background on the composition of the chicken plasma MiRNome in response to a stress. PLoS One 2014;9:e114598. [PMID: 25473826 DOI: 10.1371/journal.pone.0114598] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
464 Timmons JA. Variability in training-induced skeletal muscle adaptation. J Appl Physiol (1985) 2011;110:846-53. [PMID: 21030666 DOI: 10.1152/japplphysiol.00934.2010] [Cited by in Crossref: 130] [Cited by in F6Publishing: 119] [Article Influence: 10.8] [Reference Citation Analysis]
465 Sud N, Taher J, Su Q. MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders. Drug Dev Res 2015;76:318-27. [PMID: 26286650 DOI: 10.1002/ddr.21269] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
466 Ji C, Guo X. The clinical potential of circulating microRNAs in obesity. Nat Rev Endocrinol 2019;15:731-43. [PMID: 31611648 DOI: 10.1038/s41574-019-0260-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 16.3] [Reference Citation Analysis]
467 Li S, Chen X, Zhang H, Liang X, Xiang Y, Yu C, Zen K, Li Y, Zhang CY. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res. 2009;50:1756-1765. [PMID: 19372595 DOI: 10.1194/jlr.m800509-jlr200] [Cited by in Crossref: 142] [Cited by in F6Publishing: 74] [Article Influence: 10.9] [Reference Citation Analysis]
468 Kowalczykiewicz D, Świercz A, Handschuh L, Leśniak K, Figlerowicz M, Wrzesinski J. Characterization of Sus scrofa small non-coding RNAs present in both female and male gonads. PLoS One 2014;9:e113249. [PMID: 25415416 DOI: 10.1371/journal.pone.0113249] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
469 Chistiakov DA, Sobenin IA, Orekhov AN. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology. Drug Deliv. 2012;19:392-405. [PMID: 23173580 DOI: 10.3109/10717544.2012.738436] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
470 Fang Z, Dou G, Wang L. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Int J Biol Sci 2021;17:1851-63. [PMID: 33994867 DOI: 10.7150/ijbs.59588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
471 Ling HY, Ou HS, Feng SD, Zhang XY, Tuo QH, Chen LX, Zhu BY, Gao ZP, Tang CK, Yin WD, Zhang L, Liao DF. CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin Exp Pharmacol Physiol 2009;36:e32-9. [PMID: 19473196 DOI: 10.1111/j.1440-1681.2009.05207.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 126] [Article Influence: 10.2] [Reference Citation Analysis]
472 Hung YH, Kanke M, Kurtz CL, Cubitt RL, Bunaciu RP, Zhou L, White PJ, Vickers KC, Hussain MM, Li X, Sethupathy P. MiR-29 Regulates de novo Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner. Front Physiol 2019;10:1367. [PMID: 31736786 DOI: 10.3389/fphys.2019.01367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
473 Lim JY, Liu C, Hu KQ, Smith DE, Wang XD. Ablation of carotenoid cleavage enzymes (BCO1 and BCO2) induced hepatic steatosis by altering the farnesoid X receptor/miR-34a/sirtuin 1 pathway. Arch Biochem Biophys 2018;654:1-9. [PMID: 30006135 DOI: 10.1016/j.abb.2018.07.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
474 Tang X, Gal J, Zhuang X, Wang W, Zhu H, Tang G. A simple array platform for microRNA analysis and its application in mouse tissues. RNA 2007;13:1803-22. [PMID: 17675362 DOI: 10.1261/rna.498607] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 5.2] [Reference Citation Analysis]
475 Ruiz GP, Camara H, Fazolini NPB, Mori MA. Extracellular miRNAs in redox signaling: Health, disease and potential therapies. Free Radic Biol Med 2021;173:170-87. [PMID: 33965563 DOI: 10.1016/j.freeradbiomed.2021.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
476 Fernández-Hernando C, Baldán A. MicroRNAs and Cardiovascular Disease. Curr Genet Med Rep 2013;1:30-8. [PMID: 24563824 DOI: 10.1007/s40142-013-0008-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
477 Vliegenthart AD, Antoine DJ, Dear JW. Target biomarker profile for the clinical management of paracetamol overdose. Br J Clin Pharmacol 2015;80:351-62. [PMID: 26076366 DOI: 10.1111/bcp.12699] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
478 Gliozzi M, Musolino V, Bosco F, Scicchitano M, Scarano F, Nucera S, Zito MC, Ruga S, Carresi C, Macrì R, Guarnieri L, Maiuolo J, Tavernese A, Coppoletta AR, Nicita C, Mollace R, Palma E, Muscoli C, Belzung C, Mollace V. Cholesterol homeostasis: Researching a dialogue between the brain and peripheral tissues. Pharmacol Res 2021;163:105215. [PMID: 33007421 DOI: 10.1016/j.phrs.2020.105215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
479 Chung SW, Hall SR, Perrella MA. Role of haem oxygenase-1 in microbial host defence. Cell Microbiol 2009;11:199-207. [PMID: 19016784 DOI: 10.1111/j.1462-5822.2008.01261.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
480 Torres AG, Fabani MM, Vigorito E, Williams D, Al-Obaidi N, Wojciechowski F, Hudson RH, Seitz O, Gait MJ. Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs. Nucleic Acids Res 2012;40:2152-67. [PMID: 22070883 DOI: 10.1093/nar/gkr885] [Cited by in Crossref: 82] [Cited by in F6Publishing: 83] [Article Influence: 7.5] [Reference Citation Analysis]
481 Sharma S, Eghbali M. Influence of sex differences on microRNA gene regulation in disease. Biol Sex Differ 2014;5:3. [PMID: 24484532 DOI: 10.1186/2042-6410-5-3] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 12.3] [Reference Citation Analysis]
482 Shu J, Kren BT, Xia Z, Wong PY, Li L, Hanse EA, Min MX, Li B, Albrecht JH, Zeng Y. Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration. Hepatology. 2011;54:609-619. [PMID: 21574170 DOI: 10.1002/hep.24421] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
483 Cohen A, Shmoish M, Levi L, Cheruti U, Levavi-sivan B, Lubzens E. Alterations in Micro-Ribonucleic Acid Expression Profiles Reveal a Novel Pathway for Estrogen Regulation. Endocrinology 2008;149:1687-96. [DOI: 10.1210/en.2007-0969] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
484 Liu S, Gao S, Zhang D, Yin J, Xiang Z, Xia Q. MicroRNAs show diverse and dynamic expression patterns in multiple tissues of Bombyx mori. BMC Genomics 2010;11:85. [PMID: 20122259 DOI: 10.1186/1471-2164-11-85] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
485 Yang Z, Qin W, Huo J, Zhuo Q, Wang J, Wang L. MiR-22 modulates the expression of lipogenesis-related genes and promotes hepatic steatosis in vitro. FEBS Open Bio 2021;11:322-32. [PMID: 33159388 DOI: 10.1002/2211-5463.13026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
486 Kostyniuk DJ, Culbert BM, Mennigen JA, Gilmour KM. Social status affects lipid metabolism in rainbow trout, Oncorhynchus mykiss. Am J Physiol Regul Integr Comp Physiol 2018;315:R241-55. [PMID: 29561648 DOI: 10.1152/ajpregu.00402.2017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
487 Pacholewska A, Mach N, Mata X, Vaiman A, Schibler L, Barrey E, Gerber V. Novel equine tissue miRNAs and breed-related miRNA expressed in serum. BMC Genomics 2016;17:831. [PMID: 27782799 DOI: 10.1186/s12864-016-3168-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
488 Xu C, Yu C, Li Y. Regulation of Hepatic MicroRNA Expression in Response to Ischemic Preconditioning following Ischemia/Reperfusion Injury in Mice. OMICS: A Journal of Integrative Biology 2009;13:513-20. [DOI: 10.1089/omi.2009.0035] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
489 Li H, Ma Z, Jia L, Li Y, Xu C, Wang T, Han R, Jiang R, Li Z, Sun G, Kang X, Liu X. Systematic analysis of the regulatory functions of microRNAs in chicken hepatic lipid metabolism. Sci Rep 2016;6:31766. [PMID: 27535581 DOI: 10.1038/srep31766] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
490 Baumgarten S, Bayer T, Aranda M, Liew YJ, Carr A, Micklem G, Voolstra CR. Integrating microRNA and mRNA expression profiling in Symbiodinium microadriaticum, a dinoflagellate symbiont of reef-building corals. BMC Genomics 2013;14:704. [PMID: 24119094 DOI: 10.1186/1471-2164-14-704] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
491 Xie SS, Li XY, Liu T, Cao JH, Zhong Q, Zhao SH. Discovery of porcine microRNAs in multiple tissues by a Solexa deep sequencing approach. PLoS One 2011;6:e16235. [PMID: 21283541 DOI: 10.1371/journal.pone.0016235] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
492 Lambrecht J, Verhulst S, Reynaert H, van Grunsven LA. The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis. Cells 2019;8:E1003. [PMID: 31470644 DOI: 10.3390/cells8091003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
493 Le Guillou S, Marthey S, Laloë D, Laubier J, Mobuchon L, Leroux C, Le Provost F. Characterisation and comparison of lactating mouse and bovine mammary gland miRNomes. PLoS One 2014;9:e91938. [PMID: 24658750 DOI: 10.1371/journal.pone.0091938] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
494 Ha SY, Yu JI, Choi C, Kang SY, Joh JW, Paik SW, Kim S, Kim M, Park HC, Park CK. Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma. Sci Rep 2019;9:14738. [PMID: 31611609 DOI: 10.1038/s41598-019-50594-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
495 Tao YF, Qiang J, Yin GJ, Xu P, Shi Q, Bao JW. Identification and characterization of lipid metabolism-related microRNAs in the liver of genetically improved farmed tilapia (GIFT, Oreochromis niloticus) by deep sequencing. Fish Shellfish Immunol 2017;69:227-35. [PMID: 28838655 DOI: 10.1016/j.fsi.2017.08.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
496 Cheng G, Jin Y. MicroRNAs: potentially important regulators for schistosome development and therapeutic targets against schistosomiasis. Parasitology 2012;139:669-79. [PMID: 22309492 DOI: 10.1017/S0031182011001855] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
497 Sharma VK, Rungta P, Prasad AK. Nucleic acid therapeutics: basic concepts and recent developments. RSC Adv 2014;4:16618. [DOI: 10.1039/c3ra47841f] [Cited by in Crossref: 59] [Cited by in F6Publishing: 29] [Article Influence: 7.4] [Reference Citation Analysis]
498 Jamaluddin MS, Weakley SM, Zhang L, Kougias P, Lin PH, Yao Q, Chen C. miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn. 2011;11:79-89. [PMID: 21171923 DOI: 10.1586/erm.10.103] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
499 Eckstein F. The versatility of oligonucleotides as potential therapeutics. Expert Opin Biol Ther 2007;7:1021-34. [PMID: 17665991 DOI: 10.1517/14712598.7.7.1021] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
500 Gu Z, Eleswarapu S, Jiang H. Identification and characterization of microRNAs from the bovine adipose tissue and mammary gland. FEBS Lett. 2007;581:981-988. [PMID: 17306260 DOI: 10.1016/j.febslet.2007.01.081] [Cited by in Crossref: 107] [Cited by in F6Publishing: 104] [Article Influence: 7.1] [Reference Citation Analysis]
501 Asaoka T, Hernandez D, Tryphonopoulos P, Tekin A, Garcia J, Nishida S, Fan J, Beduschi T, Vianna R, Ruiz P. Clinical significance of intragraft miR-122 and -155 expression after liver transplantation: Intragraft expression of miRNA-122 and -155. Hepatol Res 2015;45:898-905. [DOI: 10.1111/hepr.12424] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
502 Lee IS, Park KC, Yang K, Choi H, Jang YS, Lee JM, Kim HS. Exenatide reverses dysregulated microRNAs in high-fat diet-induced obese mice. Obesity Research & Clinical Practice 2016;10:315-26. [DOI: 10.1016/j.orcp.2015.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
503 Klug BJ, Brigham RM. Changes to Metabolism and Cell Physiology that Enable Mammalian Hibernation. Springer Science Reviews 2015;3:39-56. [DOI: 10.1007/s40362-015-0030-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
504 Campos C, Sundaram AY, Valente LM, Conceição LE, Engrola S, Fernandes JM. Thermal plasticity of the miRNA transcriptome during Senegalese sole development. BMC Genomics 2014;15:525. [PMID: 24966054 DOI: 10.1186/1471-2164-15-525] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
505 Cui M, Xiao Z, Sun B, Wang Y, Zheng M, Ye L, Zhang X. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4. Biochem Biophys Res Commun 2014;445:651-5. [PMID: 24576478 DOI: 10.1016/j.bbrc.2014.02.068] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
506 Obad S, dos Santos CO, Petri A, Heidenblad M, Broom O, Ruse C, Fu C, Lindow M, Stenvang J, Straarup EM. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet. 2011;43:371-378. [PMID: 21423181 DOI: 10.1038/ng.786] [Cited by in Crossref: 460] [Cited by in F6Publishing: 443] [Article Influence: 41.8] [Reference Citation Analysis]
507 Goljanek-Whysall K, Sweetman D, Münsterberg AE. microRNAs in skeletal muscle differentiation and disease. Clin Sci (Lond) 2012;123:611-25. [PMID: 22888971 DOI: 10.1042/CS20110634] [Cited by in Crossref: 59] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
508 Botello-Manilla AE, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. Genetics and epigenetics purpose in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 2020;14:733-48. [PMID: 32552211 DOI: 10.1080/17474124.2020.1780915] [Reference Citation Analysis]
509 Teng KY, Barajas JM, Hu P, Jacob ST, Ghoshal K. Role of B Cell Lymphoma 2 in the Regulation of Liver Fibrosis in miR-122 Knockout Mice. Biology (Basel) 2020;9:E157. [PMID: 32650615 DOI: 10.3390/biology9070157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
510 Wasserman DH, Wang TJ, Brown NJ. The Vasculature in Prediabetes. Circ Res 2018;122:1135-50. [PMID: 29650631 DOI: 10.1161/CIRCRESAHA.118.311912] [Cited by in Crossref: 43] [Cited by in F6Publishing: 21] [Article Influence: 14.3] [Reference Citation Analysis]
511 Pakzad B, Rajae E, Shahrabi S, Mansournezhad S, Davari N, Azizidoost S, Saki N. T-Cell Molecular Modulation Responses in Atherosclerosis Anergy. Lab Med 2020;51:557-65. [PMID: 32106301 DOI: 10.1093/labmed/lmaa003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
512 Li G, Wu Z, Li X, Ning X, Li Y, Yang G. Biological role of microRNA-103 based on expression profile and target genes analysis in pigs. Mol Biol Rep 2011;38:4777-86. [PMID: 21152985 DOI: 10.1007/s11033-010-0615-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
513 Hatakeyama H, Murata M, Sato Y, Takahashi M, Minakawa N, Matsuda A, Harashima H. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice. Journal of Controlled Release 2014;173:43-50. [DOI: 10.1016/j.jconrel.2013.10.023] [Cited by in Crossref: 50] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
514 Pulakat L, Aroor AR, Gul R, Sowers JR. Cardiac insulin resistance and microRNA modulators. Exp Diabetes Res 2012;2012:654904. [PMID: 21977024 DOI: 10.1155/2012/654904] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
515 Davidsen PK, Gallagher IJ, Hartman JW, Tarnopolsky MA, Dela F, Helge JW, Timmons JA, Phillips SM. High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression. Journal of Applied Physiology 2011;110:309-17. [DOI: 10.1152/japplphysiol.00901.2010] [Cited by in Crossref: 209] [Cited by in F6Publishing: 207] [Article Influence: 19.0] [Reference Citation Analysis]
516 Jia Y, Ling M, Zhang L, Jiang S, Sha Y, Zhao R. Downregulation of miR-150 Expression by DNA Hypermethylation Is Associated with High 2-Hydroxy-(4-methylthio)butanoic Acid-Induced Hepatic Cholesterol Accumulation in Nursery Piglets. J Agric Food Chem 2016;64:7530-9. [DOI: 10.1021/acs.jafc.6b03615] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
517 Seoudi AM, Lashine YA, Abdelaziz AI. MicroRNA-181a - a tale of discrepancies. Expert Rev Mol Med 2012;14:e5. [PMID: 22348355 DOI: 10.1017/S1462399411002122] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
518 Letelier P, Riquelme I, Hernández AH, Guzmán N, Farías JG, Roa JC. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. Int J Mol Sci 2016;17:E791. [PMID: 27223281 DOI: 10.3390/ijms17050791] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
519 Song KH, Li T, Owsley E, Chiang JY. A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes. J Lipid Res. 2010;51:2223-2233. [PMID: 20351063 DOI: 10.1194/jlr.m004531] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
520 Zerenturk EJ, Sharpe LJ, Ikonen E, Brown AJ. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis. Prog Lipid Res 2013;52:666-80. [PMID: 24095826 DOI: 10.1016/j.plipres.2013.09.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 8.1] [Reference Citation Analysis]
521 Lemche E, Chaban OS, Lemche AV. Neuroendocrinological and Epigenetic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome. Front Neurosci 2016;10:142. [PMID: 27147943 DOI: 10.3389/fnins.2016.00142] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
522 Selitsky SR, Dinh TA, Toth CL, Kurtz CL, Honda M, Struck BR, Kaneko S, Vickers KC, Lemon SM, Sethupathy P. Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs. mBio 2015;6:e01500-15. [PMID: 26646011 DOI: 10.1128/mBio.01500-15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
523 Zhao Y, Shu R, Liu J. The development and improvement of ribonucleic acid therapy strategies. Mol Ther Nucleic Acids 2021;26:997-1013. [PMID: 34540356 DOI: 10.1016/j.omtn.2021.09.002] [Reference Citation Analysis]
524 Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J, Gandhi CR, Li S. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol. 2013;58:522-528. [PMID: 23178710 DOI: 10.1016/j.jhep.2012.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
525 Diamond DL, Syder AJ, Jacobs JM, Sorensen CM, Walters KA, Proll SC, McDermott JE, Gritsenko MA, Zhang Q, Zhao R, Metz TO, Camp DG 2nd, Waters KM, Smith RD, Rice CM, Katze MG. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 2010;6:e1000719. [PMID: 20062526 DOI: 10.1371/journal.ppat.1000719] [Cited by in Crossref: 275] [Cited by in F6Publishing: 269] [Article Influence: 22.9] [Reference Citation Analysis]
526 Martens CR, Bansal SS, Accornero F. Cardiovascular inflammation: RNA takes the lead. J Mol Cell Cardiol 2019;129:247-56. [PMID: 30880251 DOI: 10.1016/j.yjmcc.2019.03.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
527 Liang M, Liu Y, Mladinov D, Cowley AW Jr, Trivedi H, Fang Y, Xu X, Ding X, Tian Z. MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol. 2009;297:F553-F558. [PMID: 19339633 DOI: 10.1152/ajprenal.00045.2009] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 5.7] [Reference Citation Analysis]
528 Li M, Xia Y, Gu Y, Zhang K, Lang Q, Chen L, Guan J, Luo Z, Chen H, Li Y, Li Q, Li X, Jiang AA, Shuai S, Wang J, Zhu Q, Zhou X, Gao X, Li X. MicroRNAome of porcine pre- and postnatal development. PLoS One 2010;5:e11541. [PMID: 20634961 DOI: 10.1371/journal.pone.0011541] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 7.8] [Reference Citation Analysis]
529 Filipowicz M. Prognostic potential of hepatic miR-122 measurements and antisense strategies targeting miR-122 as a therapeutic approach in viral hepatitis. Liver Int 2011;31:437-9. [PMID: 21382154 DOI: 10.1111/j.1478-3231.2011.02476.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
530 Kazantseva YA, Yarushkin AA, Mostovich LA, Pustylnyak YA, Pustylnyak VO. Xenosensor CAR mediates down-regulation of miR-122 and up-regulation of miR-122 targets in the liver. Toxicol Appl Pharmacol 2015;288:26-32. [PMID: 26171734 DOI: 10.1016/j.taap.2015.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
531 Tian GP, Tang YY, He PP, Lv YC, Ouyang XP, Zhao GJ, Tang SL, Wu JF, Wang JL, Peng J. The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice. Biochem Biophys Res Commun. 2014;443:428-434. [PMID: 24309104 DOI: 10.1016/j.bbrc.2013.11.109] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
532 Lennox KA, Behlke MA. A direct comparison of anti-microRNA oligonucleotide potency. Pharm Res 2010;27:1788-99. [PMID: 20424893 DOI: 10.1007/s11095-010-0156-0] [Cited by in Crossref: 119] [Cited by in F6Publishing: 114] [Article Influence: 9.9] [Reference Citation Analysis]
533 Szabo G, Csak T. Role of MicroRNAs in NAFLD/NASH. Dig Dis Sci. 2016;61:1314-1324. [PMID: 26769057 DOI: 10.1007/s10620-015-4002-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
534 Rayner KJ, Moore KJ. MicroRNA control of high-density lipoprotein metabolism and function. Circ Res 2014;114:183-92. [PMID: 24385511 DOI: 10.1161/CIRCRESAHA.114.300645] [Cited by in Crossref: 55] [Cited by in F6Publishing: 26] [Article Influence: 6.9] [Reference Citation Analysis]
535 Qi H, Liu Z, Liu B, Cao H, Sun W, Yan Y, Zhang L. micro-RNA screening and prediction model construction for diagnosis of salt-sensitive essential hypertension. Medicine (Baltimore) 2017;96:e6417. [PMID: 28445253 DOI: 10.1097/MD.0000000000006417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
536 Feng S, Ma J, Long K, Zhang J, Qiu W, Li Y, Jin L, Wang X, Jiang A, Liu L, Xiao W, Li X, Tang Q, Li M. Comparative microRNA Transcriptomes in Domestic Goats Reveal Acclimatization to High Altitude. Front Genet 2020;11:809. [PMID: 32849809 DOI: 10.3389/fgene.2020.00809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
537 Nguyen MA, Karunakaran D, Rayner KJ. Unlocking the Door to New Therapies in Cardiovascular Disease: MicroRNAs Hold the Key. Curr Cardiol Rep. 2014;16:539. [PMID: 25303893 DOI: 10.1007/s11886-014-0539-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
538 Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology. 2007;133:1166-1174. [PMID: 17919492 DOI: 10.1053/j. gastro.2007.08.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
539 Li Y. Comparing of backfat microRNAomes of Landrace and Neijiang pig by high-throughput sequencing. Genes Genomics 2021;43:543-51. [PMID: 33725278 DOI: 10.1007/s13258-021-01078-z] [Reference Citation Analysis]
540 Casas-Agustench P, Iglesias-Gutiérrez E, Dávalos A. Mother's nutritional miRNA legacy: Nutrition during pregnancy and its possible implications to develop cardiometabolic disease in later life. Pharmacol Res 2015;100:322-34. [PMID: 26325301 DOI: 10.1016/j.phrs.2015.08.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
541 Garbacki N, Di Valentin E, Huynh-Thu VA, Geurts P, Irrthum A, Crahay C, Arnould T, Deroanne C, Piette J, Cataldo D, Colige A. MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS One 2011;6:e16509. [PMID: 21305051 DOI: 10.1371/journal.pone.0016509] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 9.1] [Reference Citation Analysis]
542 Seto AG. The road toward microRNA therapeutics. The International Journal of Biochemistry & Cell Biology 2010;42:1298-305. [DOI: 10.1016/j.biocel.2010.03.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
543 Zhou L, Liang X, Xie M, Yin J, Huang Y, Li X, Shan Z, Chen L, Zhang Y, Luo C, Liu L. A Functional Variant in SEPP1 Interacts With Plasma Selenium Concentrations on 3-Year Lipid Changes: A Prospective Cohort Study. Front Nutr 2021;8:789577. [PMID: 34950691 DOI: 10.3389/fnut.2021.789577] [Reference Citation Analysis]
544 Abu-Farha M, Cherian P, Al-Khairi I, Nizam R, Alkandari A, Arefanian H, Tuomilehto J, Al-Mulla F, Abubaker J. Reduced miR-181d level in obesity and its role in lipid metabolism via regulation of ANGPTL3. Sci Rep 2019;9:11866. [PMID: 31413305 DOI: 10.1038/s41598-019-48371-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
545 Tomankova T, Petrek M, Gallo J, Kriegova E. MicroRNAs: Emerging Regulators of Immune-Mediated Diseases. Scand J Immunol. 2012;75:129-141. [PMID: 21988491 DOI: 10.1111/j.1365-3083.2011.02650.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
546 Robledo D, Martin AP, Álvarez‐dios JA, Bouza C, Pardo BG, Martínez P. First characterization and validation of turbot microRNAs. Aquaculture 2017;472:76-83. [DOI: 10.1016/j.aquaculture.2016.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
547 Mukhadi S, Hull R, Mbita Z, Dlamini Z. The Role of MicroRNAs in Kidney Disease. Noncoding RNA 2015;1:192-221. [PMID: 29861424 DOI: 10.3390/ncrna1030192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
548 Roy S, Trautwein C, Luedde T, Roderburg C. A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases. Front Pharmacol 2018;9:805. [PMID: 30158867 DOI: 10.3389/fphar.2018.00805] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
549 Rivas GA, Rodríguez MC, Rubianes MD, Gutierrez FA, Eguílaz M, Dalmasso PR, Primo EN, Tettamanti C, Ramírez ML, Montemerlo A, Gallay P, Parrado C. Carbon nanotubes-based electrochemical (bio)sensors for biomarkers. Applied Materials Today 2017;9:566-88. [DOI: 10.1016/j.apmt.2017.10.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 9.6] [Reference Citation Analysis]
550 Stenvang J, Kauppinen S. MicroRNAs as targets for antisense-based therapeutics. Expert Opin Biol Ther 2008;8:59-81. [PMID: 18081537 DOI: 10.1517/14712598.8.1.59] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 5.9] [Reference Citation Analysis]
551 Lin XX, Lian GH, Peng SF, Zhao Q, Xu Y, Ou-Yang DS, Zhang W, Chen Y. Reversing Epigenetic Alterations Caused by Alcohol: A Promising Therapeutic Direction for Alcoholic Liver Disease. Alcohol Clin Exp Res 2018;42:1863-73. [PMID: 30080257 DOI: 10.1111/acer.13863] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
552 Adams BD, Furneaux H, White BA. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol. 2007;21:1132-1147. [PMID: 17312270 DOI: 10.1210/me.2007-0022] [Cited by in Crossref: 337] [Cited by in F6Publishing: 317] [Article Influence: 22.5] [Reference Citation Analysis]
553 Caus M, Eritja À, Bozic M. Role of microRNAs in Obesity-Related Kidney Disease. Int J Mol Sci 2021;22:11416. [PMID: 34768854 DOI: 10.3390/ijms222111416] [Reference Citation Analysis]
554 Fernández-Hernando C, Ramírez CM, Goedeke L, Suárez Y. MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 2013;33:178-85. [PMID: 23325474 DOI: 10.1161/ATVBAHA.112.300144] [Cited by in Crossref: 164] [Cited by in F6Publishing: 101] [Article Influence: 18.2] [Reference Citation Analysis]
555 Baigude H, Rana TM. Strategies to antagonize miRNA functions in vitro and in vivo. Nanomedicine (Lond) 2014;9:2545-55. [PMID: 25490425 DOI: 10.2217/nnm.14.162] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
556 Singhal A, Agrawal A, Ling J. Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs. J Cell Mol Med 2018;22:2071-85. [PMID: 29411512 DOI: 10.1111/jcmm.13553] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
557 Lin XZ, Luo J, Zhang LP, Wang W, Shi HB, Zhu JJ. MiR-27a suppresses triglyceride accumulation and affects gene mRNA expression associated with fat metabolism in dairy goat mammary gland epithelial cells. Gene 2013;521:15-23. [PMID: 23537996 DOI: 10.1016/j.gene.2013.03.050] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 8.7] [Reference Citation Analysis]
558 Calkins KL, Thamotharan S, Ghosh S, Dai Y, Devaskar SU. MicroRNA 122 Reflects Liver Injury in Children with Intestinal Failure-Associated Liver Disease Treated with Intravenous Fish Oil. J Nutr 2020;150:1144-50. [PMID: 32072161 DOI: 10.1093/jn/nxaa001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
559 Sempere LF, Kauppinen S. Translational Implications of MicroRNAs in Clinical Diagnostics and Therapeutics. Handbook of Cell Signaling. Elsevier; 2010. pp. 2965-81. [DOI: 10.1016/b978-0-12-374145-5.00340-5] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
560 Chang CT, Yang CY, Tsai FJ, Lin SY, Chen CJ. Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease. Biomed Res Int 2015;2015:164846. [PMID: 26090384 DOI: 10.1155/2015/164846] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
561 Sidorkiewicz M, Grek-Kowalinska M, Piekarska A. Changes in miR-122 and Cholesterol Expression in Chronic Hepatitis C Patients after PegIFN-Alpha/Ribavirin Treatment. Pathogens 2020;9:E514. [PMID: 32630479 DOI: 10.3390/pathogens9060514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
562 Gómez de Cedrón M, Ramírez de Molina A. Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism. J Lipid Res 2016;57:193-206. [PMID: 26630911 DOI: 10.1194/jlr.R061812] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
563 Hung J, Miscianinov V, Sluimer JC, Newby DE, Baker AH. Targeting Non-coding RNA in Vascular Biology and Disease. Front Physiol 2018;9:1655. [PMID: 30524312 DOI: 10.3389/fphys.2018.01655] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
564 Zhang Z, Liu X, Xu H, Feng X, Lin Y, Huang Y, Peng Y, Gu M. Obesity-induced upregulation of miR-361-5p promotes hepatosteatosis through targeting Sirt1. Metabolism 2018;88:31-9. [PMID: 30309516 DOI: 10.1016/j.metabol.2018.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
565 van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 2012;11:860-72. [PMID: 23080337 DOI: 10.1038/nrd3864] [Cited by in Crossref: 427] [Cited by in F6Publishing: 412] [Article Influence: 42.7] [Reference Citation Analysis]
566 Wang J, Lu R, Sun J, Xie D, Yang F, Nie G. Differential expression of lipid metabolism-related genes and miRNAs in Ctenopharyngodon idella liver in relation to fatty liver induced by high non-protein energy diets. Aquac Res 2017;48:4070-85. [DOI: 10.1111/are.13228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
567 Köberle V, Waidmann O, Kronenberger B, Andrei A, Susser S, Füller C, Perner D, Zeuzem S, Sarrazin C, Piiper A. Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy. J Viral Hepat. 2013;20:530-535. [PMID: 23808991 DOI: 10.1111/jvh.12075] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
568 Ouni M, Schürmann A. Epigenetic contribution to obesity. Mamm Genome 2020;31:134-45. [PMID: 32279091 DOI: 10.1007/s00335-020-09835-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
569 Pulito C, Sanli T, Rana P, Muti P, Blandino G, Strano S. Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention. Metabolites 2013;3:1051-75. [PMID: 24958265 DOI: 10.3390/metabo3041051] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
570 Purdy JG, Luftig MA. Reprogramming of cellular metabolic pathways by human oncogenic viruses. Curr Opin Virol 2019;39:60-9. [PMID: 31766001 DOI: 10.1016/j.coviro.2019.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
571 Yang YM, Seo SY, Kim TH, Kim SG. Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Hepatology 2012;56:2209-20. [PMID: 22807119 DOI: 10.1002/hep.25912] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 9.0] [Reference Citation Analysis]
572 Zisoulis DG. Determination of Anti-miR Association with miRNA/Argonaute Complexes In Vivo. Methods Mol Biol 2017;1517:79-89. [PMID: 27924475 DOI: 10.1007/978-1-4939-6563-2_5] [Reference Citation Analysis]
573 Wang Q, Qi R, Wang J, Huang W, Wu Y, Huang X, Yang F, Huang J. Differential expression profile of miRNAs in porcine muscle and adipose tissue during development. Gene 2017;618:49-56. [DOI: 10.1016/j.gene.2017.04.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
574 Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology. 2007;133:1166-1174. [PMID: 17919492 DOI: 10.1053/j.gastro.2007.08.002] [Cited by in Crossref: 131] [Cited by in F6Publishing: 127] [Article Influence: 8.7] [Reference Citation Analysis]
575 Whitfield M, Pollet-Villard X, Levy R, Drevet JR, Saez F. Posttesticular sperm maturation, infertility, and hypercholesterolemia. Asian J Androl 2015;17:742-8. [PMID: 26067871 DOI: 10.4103/1008-682X.155536] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
576 Liao Y, Peng Z, Chen L, Liu L, Wu Q, Yang W. Roles of microRNAs and prospective view of competing endogenous RNAs in mycotoxicosis. Mutation Research/Reviews in Mutation Research 2019;782:108285. [DOI: 10.1016/j.mrrev.2019.108285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
577 Yamada H, Suzuki K, Ichino N, Ando Y, Sawada A, Osakabe K, Sugimoto K, Ohashi K, Teradaira R, Inoue T. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta. 2013;424:99-103. [PMID: 23727030 DOI: 10.1016/j.cca.2013.05.021] [Cited by in Crossref: 186] [Cited by in F6Publishing: 177] [Article Influence: 20.7] [Reference Citation Analysis]
578 Park S, Jeong H, Yang W, Lee W. Implications of microRNAs in the pathogenesis of diabetes. Arch Pharm Res 2013;36:154-66. [DOI: 10.1007/s12272-013-0017-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
579 Atkin SL, Ramachandran V, Yousri NA, Benurwar M, Simper SC, McKinlay R, Adams TD, Najafi-Shoushtari SH, Hunt SC. Changes in Blood microRNA Expression and Early Metabolic Responsiveness 21 Days Following Bariatric Surgery. Front Endocrinol (Lausanne) 2018;9:773. [PMID: 30687230 DOI: 10.3389/fendo.2018.00773] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
580 Arguello G, Balboa E, Arrese M, Zanlungo S. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015;1852:1765-78. [DOI: 10.1016/j.bbadis.2015.05.015] [Cited by in Crossref: 127] [Cited by in F6Publishing: 134] [Article Influence: 18.1] [Reference Citation Analysis]
581 Xu S, Hazlett LD. MicroRNAs in Ocular Infection. Microorganisms 2019;7:E359. [PMID: 31533211 DOI: 10.3390/microorganisms7090359] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
582 Daimiel-ruiz L, Klett-mingo M, Konstantinidou V, Micó V, Aranda JF, García B, Martínez-botas J, Dávalos A, Fernández-hernando C, Ordovás JM. Dietary lipids modulate the expression of miR-107, a miRNA that regulates the circadian system. Mol Nutr Food Res 2015;59:1865-78. [DOI: 10.1002/mnfr.201570094] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
583 Peters LJF, Biessen EAL, Hohl M, Weber C, van der Vorst EPC, Santovito D. Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease. Front Physiol 2020;11:793. [PMID: 32733281 DOI: 10.3389/fphys.2020.00793] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
584 Vahdati Hassani F, Mehri S, Abnous K, Birner-Gruenberger R, Hosseinzadeh H. Protective effect of crocin on BPA-induced liver toxicity in rats through inhibition of oxidative stress and downregulation of MAPK and MAPKAP signaling pathway and miRNA-122 expression. Food Chem Toxicol 2017;107:395-405. [PMID: 28689058 DOI: 10.1016/j.fct.2017.07.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
585 D'Ardes D, Santilli F, Guagnano MT, Bucci M, Cipollone F. From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis. High Blood Press Cardiovasc Prev 2020;27:1-8. [PMID: 31925708 DOI: 10.1007/s40292-019-00356-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
586 Bartel S, Schulz N, Alessandrini F, Schamberger AC, Pagel P, Theis FJ, Milger K, Noessner E, Stick SM, Kicic A, Eickelberg O, Freishtat RJ, Krauss-Etschmann S. Pulmonary microRNA profiles identify involvement of Creb1 and Sec14l3 in bronchial epithelial changes in allergic asthma. Sci Rep 2017;7:46026. [PMID: 28383034 DOI: 10.1038/srep46026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
587 Butt AM, Raja AJ, Siddique S, Khan JS, Shahid M, Tayyab GU, Minhas Z, Umar M, Idrees M, Tong Y. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients. Sci Rep. 2016;6:21510. [PMID: 26898400 DOI: 10.1038/srep21510] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
588 Novák J, Bienertová-Vašků J, Kára T, Novák M. MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment. Mediators Inflamm 2014;2014:275867. [PMID: 24876669 DOI: 10.1155/2014/275867] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
589 Assmann TS, Milagro FI, Martínez JA. Crosstalk between microRNAs, the putative target genes and the lncRNA network in metabolic diseases. Mol Med Rep 2019;20:3543-54. [PMID: 31485667 DOI: 10.3892/mmr.2019.10595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
590 Su J, Baigude H, McCarroll J, Rana TM. Silencing microRNA by interfering nanoparticles in mice. Nucleic Acids Res 2011;39:e38. [PMID: 21212128 DOI: 10.1093/nar/gkq1307] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
591 Alvarez ML, DiStefano JK. Towards microRNA-based therapeutics for diabetic nephropathy. Diabetologia. 2013;56:444-456. [PMID: 23135222 DOI: 10.1007/s00125-012-2768-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
592 Elfimova N, Schlattjan M, Sowa JP, Dienes HP, Canbay A, Odenthal M. Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis. Front Physiol. 2012;3:476. [PMID: 23267332 DOI: 10.3389/fphys.2012.00476] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
593 Shah MY, Calin GA. The mix of two worlds: non-coding RNAs and hormones. Nucleic Acid Ther. 2013;23:2-8. [PMID: 23051203 DOI: 10.1089/nat.2012.0375] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
594 Silva CS, Chang CW, Williams D, Porter-Gill P, Gamboa da Costa G, Camacho L. Effects of a 28-day dietary co-exposure to melamine and cyanuric acid on the levels of serum microRNAs in male and female Fisher 344 rats. Food Chem Toxicol 2016;98:11-6. [PMID: 27621052 DOI: 10.1016/j.fct.2016.09.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
595 Raghunath A, Jeyabaskar D, Sundarraj K, Panneerselvam L, Perumal E. In silico prediction of microRNAs on fluoride induced sperm toxicity in mice. Food Chem Toxicol 2016;98:34-49. [PMID: 27012587 DOI: 10.1016/j.fct.2016.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
596 Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013;10:542-552. [PMID: 23689081 DOI: 10.1038/nrgastro.2013.87] [Cited by in Crossref: 367] [Cited by in F6Publishing: 361] [Article Influence: 40.8] [Reference Citation Analysis]
597 Budhu A, Wang XW. MicroRNAs and Gastroenterological Cancers. Drug Discov Today Dis Mech 2011;8:e95-e102. [PMID: 22582080 DOI: 10.1016/j.ddmec.2011.11.005] [Reference Citation Analysis]
598 Vickers KC, Remaley AT. MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr Opin Endocrinol Diabetes Obes. 2010;17:150-155. [PMID: 20150807 DOI: 10.1097/med.0b013e32833727a1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
599 Omran A, Elimam D, Webster KA, Shehadeh LA, Yin F. MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle. Cardiol Young 2013;23:642-55. [PMID: 23443043 DOI: 10.1017/S1047951113000048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
600 Rech M, Barandiarán Aizpurua A, van Empel V, van Bilsen M, Schroen B. Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle. Cardiovasc Res 2018;114:782-93. [PMID: 29462282 DOI: 10.1093/cvr/cvy049] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
601 Csak T, Bala S, Lippai D, Satishchandran A, Catalano D, Kodys K, Szabo G. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int. 2015;35:532-541. [PMID: 25040043 DOI: 10.1111/liv.12633] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 10.0] [Reference Citation Analysis]
602 Trattner S, Vestergren AS. Tissue distribution of selected micro RNA in Atlantic salmon. Eur J Lipid Sci Technol 2013;115:1348-56. [DOI: 10.1002/ejlt.201200428] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
603 Xiao X, Song BL. SREBP: a novel therapeutic target. Acta Biochim Biophys Sin (Shanghai) 2013;45:2-10. [PMID: 23257291 DOI: 10.1093/abbs/gms112] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 8.7] [Reference Citation Analysis]
604 Yoshioka W, Higashiyama W, Tohyama C. Involvement of microRNAs in dioxin-induced liver damage in the mouse. Toxicol Sci 2011;122:457-65. [PMID: 21602190 DOI: 10.1093/toxsci/kfr130] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
605 Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3-14. [PMID: 25979468 DOI: 10.1016/j.addr.2015.05.001] [Cited by in Crossref: 633] [Cited by in F6Publishing: 622] [Article Influence: 90.4] [Reference Citation Analysis]
606 Chu B, Wu T, Miao L, Mei Y, Wu M. MiR-181a regulates lipid metabolism via IDH1. Sci Rep 2015;5:8801. [PMID: 25739786 DOI: 10.1038/srep08801] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
607 Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer. 2007;43:1529-1544. [PMID: 17531469 DOI: 10.1016/j.ejca.2007.04.002] [Cited by in Crossref: 229] [Cited by in F6Publishing: 219] [Article Influence: 15.3] [Reference Citation Analysis]
608 Oses M, Margareto Sanchez J, Portillo MP, Aguilera CM, Labayen I. Circulating miRNAs as Biomarkers of Obesity and Obesity-Associated Comorbidities in Children and Adolescents: A Systematic Review. Nutrients 2019;11:E2890. [PMID: 31783635 DOI: 10.3390/nu11122890] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
609 Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 2009;9:703-711. [PMID: 19426115 DOI: 10.1517/14712590902932889] [Cited by in Crossref: 299] [Cited by in F6Publishing: 284] [Article Influence: 23.0] [Reference Citation Analysis]
610 Soubeyrand S, Martinuk A, Naing T, Lau P, McPherson R. Role of Tribbles Pseudokinase 1 (TRIB1) in human hepatocyte metabolism. Biochim Biophys Acta 2016;1862:223-32. [PMID: 26657055 DOI: 10.1016/j.bbadis.2015.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
611 Starlinger P, Hackl H, Pereyra D, Skalicky S, Geiger E, Finsterbusch M, Tamandl D, Brostjan C, Grünberger T, Hackl M, Assinger A. Predicting Postoperative Liver Dysfunction Based on Blood-Derived MicroRNA Signatures. Hepatology 2019;69:2636-51. [PMID: 30779441 DOI: 10.1002/hep.30572] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
612 Goedeke L, Aranda JF, Fernández-Hernando C. microRNA regulation of lipoprotein metabolism. Curr Opin Lipidol 2014;25:282-8. [PMID: 24978143 DOI: 10.1097/MOL.0000000000000094] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
613 Czaja AJ. Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management. Expert Rev Gastroenterol Hepatol 2018;12:547-64. [PMID: 29540068 DOI: 10.1080/17474124.2018.1453356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
614 Shizu R, Shindo S, Yoshida T, Numazawa S. MicroRNA-122 down-regulation is involved in phenobarbital-mediated activation of the constitutive androstane receptor. PLoS One 2012;7:e41291. [PMID: 22815988 DOI: 10.1371/journal.pone.0041291] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
615 Renaud L, Silveira WAD, Hazard ES, Simpson J, Falcinelli S, Chung D, Carnevali O, Hardiman G. The Plasticizer Bisphenol A Perturbs the Hepatic Epigenome: A Systems Level Analysis of the miRNome. Genes (Basel) 2017;8:E269. [PMID: 29027980 DOI: 10.3390/genes8100269] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
616 Andreou I, Sun X, Stone PH, Edelman ER, Feinberg MW. miRNAs in atherosclerotic plaque initiation, progression, and rupture. Trends Mol Med 2015;21:307-18. [PMID: 25771097 DOI: 10.1016/j.molmed.2015.02.003] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 12.6] [Reference Citation Analysis]
617 Li X, Ma J, Fang Q, Li Y. Transcription alterations of microRNAs, cytochrome P4501A1 and 3A65, and AhR and PXR in the liver of zebrafish exposed to crude microcystins. Toxicon 2013;73:17-22. [PMID: 23851223 DOI: 10.1016/j.toxicon.2013.07.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
618 Goedeke L, Fernandez-Hernando C. microRNAs: A connection between cholesterol metabolism and neurodegeneration. Neurobiol Dis. 2014; Jun 5. [Epub ahead of print]. [PMID: 24907491 DOI: 10. 1016/j.nbd.2014.05.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
619 Huang CW, Li YH, Hu SY, Chi JR, Lin GH, Lin CC, Gong HY, Chen JY, Chen RH, Chang SJ, Liu FG, Wu JL. Differential expression patterns of growth-related microRNAs in the skeletal muscle of Nile tilapia (Oreochromis niloticus)1. Journal of Animal Science 2012;90:4266-79. [DOI: 10.2527/jas.2012-5142] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
620 Zhou H, Tang W, Yang J, Peng J, Guo J, Fan C. MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure. Front Cardiovasc Med 2021;8:773083. [PMID: 34869689 DOI: 10.3389/fcvm.2021.773083] [Reference Citation Analysis]
621 Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun. 2010;391:316-321. [PMID: 19913496 DOI: 10.1016/j.bbrc.2009.11.056] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 7.2] [Reference Citation Analysis]
622 Li LM, Wang D, Zen K. MicroRNAs in Drug-induced Liver Injury. J Clin Transl Hepatol. 2014;2:162-169. [PMID: 26357624 DOI: 10.14218/jcth.2014.00015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
623 Pedroza-Torres A, Romero-Córdoba SL, Justo-Garrido M, Salido-Guadarrama I, Rodríguez-Bautista R, Montaño S, Muñiz-Mendoza R, Arriaga-Canon C, Fragoso-Ontiveros V, Álvarez-Gómez RM, Hernández G, Herrera LA. MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities. Front Oncol 2019;9:1404. [PMID: 31921661 DOI: 10.3389/fonc.2019.01404] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
624 Hsu SH, Delgado ER, Otero PA, Teng KY, Kutay H, Meehan KM, Moroney JB, Monga JK, Hand NJ, Friedman JR, Ghoshal K, Duncan AW. MicroRNA-122 regulates polyploidization in the murine liver. Hepatology 2016;64:599-615. [PMID: 27016325 DOI: 10.1002/hep.28573] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
625 Porciuncula A, Zapata N, Guruceaga E, Agirre X, Barajas M, Prosper F. MicroRNA signatures of iPSCs and endoderm-derived tissues. Gene Expr Patterns 2013;13:12-20. [PMID: 22982176 DOI: 10.1016/j.gep.2012.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
626 Langner HK, Jastrzebska K, Caruthers MH. Synthesis and Characterization of Thiophosphoramidate Morpholino Oligonucleotides and Chimeras. J Am Chem Soc 2020;142:16240-53. [PMID: 32866014 DOI: 10.1021/jacs.0c04335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
627 Zhang J, Zhang F, Didelot X, Bruce KD, Cagampang FR, Vatish M, Hanson M, Lehnert H, Ceriello A, Byrne CD. Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. BMC Genomics. 2009;10:478. [PMID: 19835573 DOI: 10.1186/1471-2164-10-478] [Cited by in Crossref: 141] [Cited by in F6Publishing: 121] [Article Influence: 10.8] [Reference Citation Analysis]
628 Rigo F, Seth PP, Bennett CF. Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects. Adv Exp Med Biol 2014;825:303-52. [PMID: 25201110 DOI: 10.1007/978-1-4939-1221-6_9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
629 Tian Y, Mok MT, Yang P, Cheng AS. Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis. Cancers (Basel) 2016;8:E76. [PMID: 27556491 DOI: 10.3390/cancers8080076] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
630 Hu M, Huang X, Han X, Ji L. Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3. Diabetes Metab Syndr Obes 2020;13:627-39. [PMID: 32184642 DOI: 10.2147/DMSO.S236915] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
631 Lendvai G, Kiss A, Kovalszky I, Schaff Z. [Alterations in microRNA expression patterns in liver diseases]. Orv Hetil 2010;151:1843-53. [PMID: 20980222 DOI: 10.1556/OH.2010.28985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
632 Baek J, Kang S, Min H. MicroRNA-targeting therapeutics for hepatitis C. Arch Pharm Res. 2014;37:299-305. [PMID: 24385319 DOI: 10.1007/s12272-013-0318-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
633 Schmelzer C, Kitano M, Rimbach G, Niklowitz P, Menke T, Hosoe K, Döring F. Effects of ubiquinol-10 on microRNA-146a expression in vitro and in vivo. Mediators Inflamm 2009;2009:415437. [PMID: 19390647 DOI: 10.1155/2009/415437] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
634 Najafi-Shoushtari SH. MicroRNAs in cardiometabolic disease. Curr Atheroscler Rep 2011;13:202-7. [PMID: 21461683 DOI: 10.1007/s11883-011-0179-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
635 Li Y, Yang N, Dong B, Yang J, Kou L, Qin Q. MicroRNA-122 promotes endothelial cell apoptosis by targeting XIAP: Therapeutic implication for atherosclerosis. Life Sci 2019;232:116590. [PMID: 31228514 DOI: 10.1016/j.lfs.2019.116590] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
636 Kuang J, Chen L, Tang Q, Zhang J, Li Y, He J. The Role of Sirt6 in Obesity and Diabetes. Front Physiol 2018;9:135. [PMID: 29535637 DOI: 10.3389/fphys.2018.00135] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
637 Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, Aukrust P, van Berkel TJ, Biessen EA. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun. 2010;394:792-797. [PMID: 20230787 DOI: 10.1016/j.bbrc.2010.03.075] [Cited by in Crossref: 153] [Cited by in F6Publishing: 152] [Article Influence: 12.8] [Reference Citation Analysis]
638 Wang XW, Heegaard NH, Orum H. MicroRNAs in liver disease. Gastroenterology 2012;142:1431-43. [PMID: 22504185 DOI: 10.1053/j.gastro.2012.04.007] [Cited by in Crossref: 201] [Cited by in F6Publishing: 197] [Article Influence: 20.1] [Reference Citation Analysis]
639 Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F. microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther 2010;125:92-104. [PMID: 19896977 DOI: 10.1016/j.pharmthera.2009.10.003] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 9.5] [Reference Citation Analysis]
640 Tang ZH, Zeng F, Zhang XZ. Human genetics of diabetic nephropathy. Ren Fail 2015;37:363-71. [PMID: 25594612 DOI: 10.3109/0886022X.2014.1000801] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
641 Huang X, Gong S, Ma Y, Cai X, Zhou L, Luo Y, Li M, Liu W, Zhang S, Zhang X, Ren Q, Zhu Y, Zhou X, Zhang R, Chen L, Gao X, Zhang F, Wang Y, Han X, Ji L. Lower Circulating miR-122 Level in Patients with HNF1A Variant-Induced Diabetes Compared with Type 2 Diabetes. J Diabetes Res 2018;2018:7842064. [PMID: 30155490 DOI: 10.1155/2018/7842064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
642 Mattis AN, Song G, Hitchner K, Kim RY, Lee AY, Sharma AD, Malato Y, McManus MT, Esau CC, Koller E. A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver. Hepatology. 2015;61:141-152. [PMID: 25131933 DOI: 10.1002/hep.27379] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
643 Gottwein E, Cullen BR. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 2008;3:375-87. [PMID: 18541214 DOI: 10.1016/j.chom.2008.05.002] [Cited by in Crossref: 301] [Cited by in F6Publishing: 303] [Article Influence: 21.5] [Reference Citation Analysis]
644 Gupta P, Cairns MJ, Saksena NK. Regulation of gene expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma. Virol J. 2014;11:64. [PMID: 24690114 DOI: 10.1186/1743-422x-11-64] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
645 Roberts AP, Lewis AP, Jopling CL. The role of microRNAs in viral infection. Prog Mol Biol Transl Sci 2011;102:101-39. [PMID: 21846570 DOI: 10.1016/B978-0-12-415795-8.00002-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
646 Wu X, Du X, Yang Y, Liu X, Liu X, Zhang N, Li Y, Jiang X, Jiang Y, Yang Z. Inhibition of miR-122 reduced atherosclerotic lesion formation by regulating NPAS3-mediated endothelial to mesenchymal transition. Life Sci 2021;265:118816. [PMID: 33278397 DOI: 10.1016/j.lfs.2020.118816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
647 Huang R, Duan X, Fan J, Li G, Wang B. Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease. Biomed Res Int 2019;2019:8690592. [PMID: 30931332 DOI: 10.1155/2019/8690592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
648 Wang EHC, Destefano GM, Patel AV, Drill E, Harel S, Cela C, Tavazoie M, Christiano AM. Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways. Genes Immun 2017;18:100-4. [DOI: 10.1038/gene.2017.4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
649 Song K, Han C, Zhang J, Lu D, Dash S, Feitelson M, Lim K, Wu T. Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells. Hepatology. 2013;58:1681-1692. [PMID: 23703729 DOI: 10.1002/hep.26514] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 9.6] [Reference Citation Analysis]
650 Ding SL, Zhou LY, Li PF. MicroRNAs in cardiac hypertrophy: angels or devils. Wiley Interdiscip Rev RNA 2011;2:124-34. [PMID: 21956973 DOI: 10.1002/wrna.61] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
651 Ceccarelli S, Nobili V, Alisi A. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. World J Gastroenterol 2014; 20(44): 16443-16451 [PMID: 25469012 DOI: 10.3748/wjg.v20.i44.16443] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
652 Guo J, Zhao W, Zhan S, Li L, Zhong T, Wang L, Dong Y, Zhang H. Identification and Expression Profiling of miRNAome in Goat longissimus dorsi Muscle from Prenatal Stages to a Neonatal Stage. PLoS One 2016;11:e0165764. [PMID: 27798673 DOI: 10.1371/journal.pone.0165764] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
653 Mocchegiani E, Costarelli L, Giacconi R, Malavolta M, Basso A, Piacenza F, Ostan R, Cevenini E, Gonos ES, Franceschi C, Monti D. Vitamin E-gene interactions in aging and inflammatory age-related diseases: implications for treatment. A systematic review. Ageing Res Rev 2014;14:81-101. [PMID: 24418256 DOI: 10.1016/j.arr.2014.01.001] [Cited by in Crossref: 76] [Cited by in F6Publishing: 58] [Article Influence: 9.5] [Reference Citation Analysis]
654 Krützfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T, Manoharan M, Stoffel M. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 2007;35:2885-92. [PMID: 17439965 DOI: 10.1093/nar/gkm024] [Cited by in Crossref: 331] [Cited by in F6Publishing: 314] [Article Influence: 22.1] [Reference Citation Analysis]
655 Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach BD. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA. 2007;104:12884-12889. [PMID: 17616579 DOI: 10.1073/pnas.0704894104] [Cited by in Crossref: 416] [Cited by in F6Publishing: 412] [Article Influence: 27.7] [Reference Citation Analysis]
656 Sekine S, Ogawa R, Ito R, Hiraoka N, McManus MT, Kanai Y, Hebrok M. Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. Gastroenterology 2009;136:2304-2315.e1-4. [PMID: 19272382 DOI: 10.1053/j.gastro.2009.02.067] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 9.8] [Reference Citation Analysis]
657 Sun J, Zhao L, Wu H, Lian W, Cui C, Du Z, Luo W, Li M, Yang S. Analysis of miRNA-seq in the liver of common carp (Cyprinus carpio L.) in response to different environmental temperatures. Funct Integr Genomics 2019;19:265-80. [DOI: 10.1007/s10142-018-0643-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
658 Benatti RO, Melo AM, Borges FO, Ignacio-souza LM, Simino LAP, Milanski M, Velloso LA, Torsoni MA, Torsoni AS. Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 ( miR-122 ) and microRNA-370 ( miR-370 ) expression in offspring. Br J Nutr 2014;111:2112-22. [DOI: 10.1017/s0007114514000579] [Cited by in Crossref: 89] [Cited by in F6Publishing: 43] [Article Influence: 11.1] [Reference Citation Analysis]
659 Eynon N, Ruiz JR, Oliveira J, Duarte JA, Birk R, Lucia A. Genes and elite athletes: a roadmap for future research. J Physiol 2011;589:3063-70. [PMID: 21540342 DOI: 10.1113/jphysiol.2011.207035] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
660 Deng S, Lang J, Coukos G, Zhang L. Expression profile of microRNA in epithelial cancer: diagnosis, classification and prediction. Expert Opin Med Diagn 2009;3:25-36. [PMID: 23495961 DOI: 10.1517/17530050802651553] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
661 Lim E, Lim JY, Kim E, Kim YS, Shin JH, Seok PR, Jung S, Yoo SH, Kim Y. Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice. Nutrients 2016;8:E791. [PMID: 27929393 DOI: 10.3390/nu8120791] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
662 Norman KL, Sarnow P. Hepatitis C virus' Achilles' heel--dependence on liver-specific microRNA miR-122. Cell Res 2010;20:247-9. [PMID: 20190773 DOI: 10.1038/cr.2010.28] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
663 Chen L, Kang C. miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks. Oncotarget 2015;6:38628-42. [PMID: 26439688 DOI: 10.18632/oncotarget.5926] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
664 La Sala L, Mrakic-Sposta S, Tagliabue E, Prattichizzo F, Micheloni S, Sangalli E, Specchia C, Uccellatore AC, Lupini S, Spinetti G, de Candia P, Ceriello A. Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D. Cardiovasc Diabetol 2019;18:18. [PMID: 30803440 DOI: 10.1186/s12933-019-0824-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
665 Yu J, Peng J, Luan Z, Zheng F, Su W. MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease. Molecules 2019;24:E230. [PMID: 30634538 DOI: 10.3390/molecules24020230] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
666 Ruberti F, Barbato C, Cogoni C. Targeting microRNAs in neurons: tools and perspectives. Exp Neurol 2012;235:419-26. [PMID: 22085592 DOI: 10.1016/j.expneurol.2011.10.031] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
667 Deng W, Lu M. The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication. Virol Sin 2016;31:472-9. [PMID: 28063013 DOI: 10.1007/s12250-016-3924-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
668 Wahid F, Khan T, Kim YY. MicroRNA and diseases: therapeutic potential as new generation of drugs. Biochimie 2014;104:12-26. [PMID: 24859535 DOI: 10.1016/j.biochi.2014.05.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
669 Liu F, Li R, Zhang Y, Qiu J, Ling W. Association of plasma MiR-17-92 with dyslipidemia in patients with coronary artery disease. Medicine (Baltimore) 2014;93:e98. [PMID: 25415674 DOI: 10.1097/MD.0000000000000098] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
670 Gholami M, Larijani B, Zahedi Z, Mahmoudian F, Bahrami S, Omran SP, Saadatian Z, Hasani-Ranjbar S, Taslimi R, Bastami M, Amoli MM. Inflammation related miRNAs as an important player between obesity and cancers. J Diabetes Metab Disord 2019;18:675-92. [PMID: 31890692 DOI: 10.1007/s40200-019-00459-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
671 Hsu SH, Wang B, Kutay H, Bid H, Shreve J, Zhang X, Costinean S, Bratasz A, Houghton P, Ghoshal K. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. Am J Pathol 2013;183:1719-30. [PMID: 24113455 DOI: 10.1016/j.ajpath.2013.08.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
672 Wijnen WJ, Pinto YM, Creemers EE. The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand? J Cardiovasc Transl Res 2013;6:899-908. [PMID: 23821466 DOI: 10.1007/s12265-013-9483-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
673 Liang T, Liu C, Ye Z. Deep sequencing of small RNA repertoires in mice reveals metabolic disorders-associated hepatic miRNAs. PLoS One. 2013;8:e80774. [PMID: 24260478 DOI: 10.1371/journal.pone.0080774] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
674 Tang Z, Fang Z, Zhou L. Human genetics of diabetic vascular complications. J Genet 2013;92:677-94. [DOI: 10.1007/s12041-013-0288-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
675 Subramanian RR, Wysk MA, Ogilvie KM, Bhat A, Kuang B, Rockel TD, Weber M, Uhlmann E, Krieg AM. Enhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers. Nucleic Acids Res 2015;43:9123-32. [PMID: 26446989 DOI: 10.1093/nar/gkv992] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
676 Banini BA, Sanyal AJ. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clin Med Insights Ther 2016;8:75-84. [PMID: 28670148 DOI: 10.4137/cmt.s18885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
677 Chen Y, Li L, Zhou Z, Wang N, Zhang CY, Zen K. A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection. Med Microbiol Immunol. 2012;201:389-395. [PMID: 22392036 DOI: 10.1007/s00430-011-0223-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
678 Chai C, Galun E, Giladi H. Reply. Gastroenterology 2018;154:1553-4. [PMID: 29526723 DOI: 10.1053/j.gastro.2018.03.018] [Reference Citation Analysis]
679 Sekiba K, Otsuka M, Ohno M, Yamagami M, Kishikawa T, Suzuki T, Ishibashi R, Seimiya T, Tanaka E, Koike K. Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA. World J Gastroenterol 2018; 24(21): 2261-2268 [PMID: 29881235 DOI: 10.3748/wjg.v24.i21.2261] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
680 Mouton-liger F, Paquet C, Hugon J. Biogenesis and regulation of microRNA: implication in Alzheimer’s disease. Future Neurology 2010;5:839-50. [DOI: 10.2217/fnl.10.58] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
681 Wang SS, Wu LJ, Li JJ, Xiao HB, He Y, Yan YX. A meta-analysis of dysregulated miRNAs in coronary heart disease. Life Sci 2018;215:170-81. [PMID: 30423308 DOI: 10.1016/j.lfs.2018.11.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
682 Qiu Z, Dai Y. Roadmap of miR-122-related clinical application from bench to bedside. Expert Opin Investig Drugs 2014;23:347-55. [PMID: 24354366 DOI: 10.1517/13543784.2014.867327] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
683 Oura K, Morishita A, Masaki T. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Int J Mol Sci 2020;21:E8362. [PMID: 33171811 DOI: 10.3390/ijms21218362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
684 Li ZY, Xi Y, Zhu WN, Zeng C, Zhang ZQ, Guo ZC, Hao DL, Liu G, Feng L, Chen HZ. Positive regulation of hepatic miR-122 expression by HNF4α. J Hepatol. 2011;55:602-611. [PMID: 21241755 DOI: 10.1016/j.jhep.2010.12.023] [Cited by in Crossref: 94] [Cited by in F6Publishing: 91] [Article Influence: 8.5] [Reference Citation Analysis]
685 Nassirpour R, Mehta PP, Yin MJ. miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3. PLoS One 2013;8:e79655. [PMID: 24244539 DOI: 10.1371/journal.pone.0079655] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
686 Ceccarelli S, Panera N, Gnani D, Nobili V. Dual Role of MicroRNAs in NAFLD. Int J Mol Sci. 2013;14:8437-8455. [PMID: 23594995 DOI: 10.3390/ijms14048437] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
687 Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, Hsu MT, Wu JC, Huang HD, Shiao MS, Hsiao M, Tsou AP. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 2012;122:2884-97. [PMID: 22820290 DOI: 10.1172/JCI63455] [Cited by in Crossref: 562] [Cited by in F6Publishing: 348] [Article Influence: 56.2] [Reference Citation Analysis]
688 Jeon TI, Osborne TF. miRNA and cholesterol homeostasis. Biochim Biophys Acta 2016;1861:2041-6. [PMID: 26778752 DOI: 10.1016/j.bbalip.2016.01.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
689 Twycross-Lewis R, Kilduff LP, Wang G, Pitsiladis YP. The effects of creatine supplementation on thermoregulation and physical (cognitive) performance: a review and future prospects. Amino Acids 2016;48:1843-55. [PMID: 27085634 DOI: 10.1007/s00726-016-2237-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
690 Khalifa O, Errafii K, Al-Akl NS, Arredouani A. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. Dis Markers 2020;2020:8822859. [PMID: 33133304 DOI: 10.1155/2020/8822859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
691 Gjorgjieva M, Sobolewski C, Dolicka D, Correia de Sousa M, Foti M. miRNAs and NAFLD: from pathophysiology to therapy. Gut 2019;68:2065-79. [PMID: 31300518 DOI: 10.1136/gutjnl-2018-318146] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 13.7] [Reference Citation Analysis]
692 Kemper JK, Choi SE, Kim DH. Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism. Vitam Horm 2013;91:385-404. [PMID: 23374725 DOI: 10.1016/B978-0-12-407766-9.00016-X] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
693 Lu YL, Jing W, Feng LS, Zhang L, Xu JF, You TJ, Zhao J. Effects of hypoxic exercise training on microRNA expression and lipid metabolism in obese rat livers. J Zhejiang Univ Sci B 2014;15:820-9. [PMID: 25183036 DOI: 10.1631/jzus.B1400052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
694 Yang Z, Cappello T, Wang L. Emerging role of microRNAs in lipid metabolism. Acta Pharm Sin B 2015;5:145-50. [PMID: 26579440 DOI: 10.1016/j.apsb.2015.01.002] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 12.9] [Reference Citation Analysis]